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Abstract
Globally, infectious diseases are responsible for major conservation and economic
losses in wild and farmed fish populations. Prevention tools, including vaccination
and breeding for genetic disease resistance, are used in many systems to prevent
mortality by such diseases. Studies are often done to evaluate the efficacy of a
preventative method at reducing disease, but the impact on transmission is rarely
studied. Protection under diverse field conditions, such as variable pathogen
exposure dosages, is also not fully understood. Furthermore, there is little
information on how preventative methods alter host-pathogen relationships. For
example, it is largely unknown how vaccination impacts non-target pathogens that
co-infect the host. These knowledge gaps make it difficult to infer the
epidemiological impacts of disease prevention tools. In an attempt to fill these
gaps, we investigated two leading pathogens in rainbow trout (Oncorhynchus
mykiss) aquaculture: infectious hematopoietic necrosis virus (IHNV) and
Flavobacterium psychrophilum. We evaluated the impacts of vaccination and
genetic disease resistance on mortality and transmission across a range of
challenge dosages of IHNV and F. psychrophilum to accurately reflect field
variability. There was evidence of a dosage effect; as dosage increased, shedding
increased and vaccine efficacy decreased. We also evaluated how vaccination and
genetic disease resistance impact transmission dynamics during simultaneous
and sequential co-infection of IHNV and F. psychrophilum. Our results indicate coinfected fish shed more of both pathogens than they do in single infections, and
the order that the pathogen infected the host may impact transmission in both
pathogens. Furthermore, vaccine efficacy may be diminished by co-infection.
These studies are aimed at developing a more robust framework for inferring the
efficacy of disease prevention strategies. Our results will also help to inform and
improve disease management in one of the top aquaculture species in the United
States.
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The effect of vaccination and genetic disease resistance on transmission
dynamics of infectious hematopoietic necrosis virus and Flavobacterium
psychrophilum in rainbow trout (Oncorhynchus mykiss)

General Introduction
Vaccination and genetically bred disease resistance have been used to
prevent disease in wildlife and domesticated animals for decades (Lombard et
al., 2007; Servat et al., 2007; Stern & Markel, 2005). However, pathogen
transmission and epidemiology in response to vaccination and resistance
breeding are poorly understood. Evidence of transmission of a pathogen from
vaccinated hosts to unvaccinated hosts has been documented in laboratory
studies where baboons were exposed to Pertussis (Warfel et al., 2014), rainbow
trout exposed to IHNV (Long et al., 2017), in the field with Marek’s disease in
chickens (Fakhrul Islam et al., 2008) and in other case-control studies using live
attenuated vaccines such as oral polio (Sutter et al., 1991). Transmission has
also been seen from hosts that have been selectively bred (Pulkkinen et al.
2009). The primary goal of vaccines and selective breeding is to prevent the
organism from developing clinical disease and dying. However, if vaccinated or
selectively bred individuals maintain transmission, then it is virtually impossible to
eradicate the pathogen, often leading to downstream complications. It can result
in persistence of the disease, particularly where vaccine coverage is poor, or
potential evolutionary responses, such as the evolution of increased virulence
(Gandon et al., 2001; Lipsitch & Moxon, 1997).
The primary objective of my doctoral thesis was to investigate how
vaccines and genetic disease resistance change pathogen transmission
dynamics in single and co-infections in rainbow trout. To do so, I quantified the
impacts of vaccination and genetic disease resistance on pathogen shedding
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kinetics as a proxy for transmission. I investigated this in infectious hematopoietic
necrosis virus (IHNV) and Flavobacterium psychrophilum in rainbow trout
(Oncorhynchus mykiss). These pathogens have been responsible for recent
world-wide outbreaks that have had major impacts on the aquaculture and
conservation of salmonids (Bootland & Leong, 2011; Lafferty et al., 2015). I used
a combination of highly replicated in vivo laboratory experiments and statistical
modelling.
Infectious hematopoietic necrosis virus (IHNV) is a single-stranded, negativesense RNA virus of the Rhabdoviradae family (Bootland & Leong, 1999). It is an
endemic virus found in salmonid species along the Pacific coast of North
America, where it is believed to have originated, and regularly causes epidemics
in trout farms and hatcheries (Troyer et al., 2000). It was first described in the
1950s (Rucker et al., 1953), and has since spread to Italy, France, Germany,
Japan, Taiwan, China and other areas of the United States, most likely through
trout aquaculture (Suttle, 2007). The virus is transmitted horizontally through the
water via bodily secretions (milt, sperm, eggs, feces, urine, mucus, etc.), carcass
degradation, or by cohabitation with infected fish (Suttle, 2007; Traxler et al.,
1993). It causes a rapid onset of signs such as exophthalmia, discoloration of the
skin, and necrosis of the kidney and spleen. In some cases it can cause up to
100% mortality (Bootland & Leong, 1999). There are many different strains of the
virus, which in the USA are categorized into three genogroups. The U genogroup
spans from Alaska to the Oregon coast, the M genogroup is found in the middle
Pacific Northwest, and the L genogroup is found in the lower Pacific Northwest
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(Kurath et al., 2003). Within each genogroup there are different strains that range
in virulence, and each genogroup is host specific (Kell et al., 2014). For example,
the U genogroup is most virulent in sockeye salmon (Oncorhynchus nerka), the
M genogroup is most virulent in rainbow trout (Oncorhynchus mykiss) (Garver et
al., 2006), and the L group is most virulent in chinook salmon (Oncorhynchus
tshawytscha). The M clade is the most diverse and likely evolved out of the U
clade when live sockeye salmon viscera were fed to rainbow trout in the Idaho
trout farm region (Kurath et al., 2003).
Flavobacterium psychrophilum is a gram-negative bacterium and the
causative agent of rainbow trout fry syndrome (RTFS) and bacterial cold-water
disease (BCWD) (Lafrentz & Cain, 2004). F. psychrophilum was first
characterized in the 1940s, (Davis, 1946); however it has had many different
names, such as Cytophaga psychrophila and Flexibacter psychrophilus
(Bernardet et al., 1996), because it was seen in different places around the world
and exhibited different clinical presentations depending on the host and
environment (Nematollahi et al., 2003). In 1996, (Bernardet et al.) these various
pathogens were recognized to be one species and given the name F.
psychrophilum. Originally it was thought to be restricted to North America
(Anderson & Conroy, 1969), but it can now be found globally (Amita et al., 2000;
Bernardet et al., 1988; Rangdale et al., 1997). In rainbow trout, the pathogen
causes anemia, dark skin pigmentation, splenomegaly, and tissue necrosis. It is
usually identifiable by a lesion near the caudal fin (Barnes & Brown, 2011). This
opportunistic pathogen causes acute disease which can result in high mortality
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rates of more than 90% (Nilsen et al., 2011). Since its discovery, new strains
have been described (Valdebenito & Avendaño-Herrera, 2009), and virulence
between strains is highly variable (Nematollahi et al., 2003).
Both IHNV and F. psychrophilum can now be detected worldwide in over two
dozen fish species, but are most problematic in salmonids, threatening wild stock
conservation and management (Algers et al., 2008). In the United States, they
are the top two leading causes of mortality in rainbow trout aquaculture systems
(Algers et al., 2008). Juvenile trout are most susceptible to the pathogens and
suffer acute systematic infections. Larger fish are readily infected, but clinically
show less severe infections. During outbreaks, there are often occurrences of coinfection (Cipriano & Holt, 2005). Yet how the pathogens affect each other during
co-infection is poorly understood. Because of the high impact on aquaculture,
management tools such as vaccination and genetically bred disease resistance
have been implemented to help reduce mortality (LaPatra et al., 2001; Wiens et
al., 2013).
Rainbow trout (Oncorhynchus mykiss) represent a great model system with
relevance to human, wildlife, and domesticated animals. Rainbow trout are wellstudied, easy-to-raise, cost-effective animals for research, allowing for large
scale, in vivo experiments with high statistical power. Fish also have dendritic
cells that are very similar to those of mammals and bridge the gap between the
innate and adaptive immune system. Because of these cells, vaccines induce an
adaptive immunity in fish that is similar to that in humans (Bassity & Clark, 2012;
Ramirez-Gomez et al., 2012; Workenhe et al., 2010) This is important because it
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allows for investigation of how vaccine induced immunity impacts transmission in
animal and human systems. Furthermore, a very efficient vaccine has been
developed for IHNV (Corbeil et al., 2000). Likewise, fish lines selectively bred for
resistance against Flavobacterium psychrophilum have been developed (Wiens
et al., 2013). Due to the development of both prevention methods, impacts of
vaccination and genetic disease resistance on transmission can be studied in the
same host using single or co-infections of the two pathogens.
My dissertation evaluated the impacts of vaccination and genetic resistance
on transmission and the epidemiology of IHNV and Flavobacterium
psychrophilum. This work represents one of the first large-scale studies looking
at the impacts of vaccination and genetically bred disease resistance on
transmission using two different pathogens in the same host. I quantified the
infectivity and transmission potential of IHNV and F. psychrophilum at different
challenge dosages in vaccinated and unvaccinated hosts, and genetically
resistant and susceptible fish, respectively. A range of dosage was tested to
more accurately reflect field conditions. The efficacy of vaccination and selective
breeding for genetic resistance is typically tested under one pathogen exposure
dose. However, protection efficacy, particularly in the context of infection and
transmission blocking, may be a function of exposure dose (Langwig et al.,
2017). Simply looking at high or low dosages, as is usually done, is less
informative because you might reach a saturation point where differences
between different dose responses are masked (Gomes et al., 2014). As such, it
is difficult to predict field efficacy because repeated high-level exposure in the
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field might overwhelm protection. Investigation of multiple dosages also allowed
for quantification of heterogeneity in host susceptibility (Gomes et al., 2014;
Langwig et al., 2017).
In the field, multiple pathogen species often co-infect a single host. However,
little has been done to look at how vaccine or genetic disease resistance against
one pathogen impacts the other, or how vaccine and selective breeding efficacy
are impacted by co-infection. In some cases, co-infection may benefit the host,
by reducing clinical disease (Alonso et al., 2003; van den Hurk et al., 2012). In
other cases, it could be beneficial to one or both parasites, and result in higher
levels of disease (Alizon et al., 2013; de Roode et al., 2004; Hawley & Altizer,
2011; Munson et al., 2008). Evidence from the field indicates co-infection
exacerbates disease for IHNV and F. psychrophilum (LaFrentz et al., 2004). For
that reason, I looked at multiple species infections in vaccinated or genetically
disease-resistant hosts to determine how co-infections affect shedding kinetics
and transmission as well as protection efficacy provided by vaccination and
selective breeding.
It is highly unlikely that both pathogens infect the host at the same time in a
simultaneous co-infection. A more probable scenario is that one pathogen infects
the host first followed by a secondary infection, known as sequential co-infection.
Because the order of infection may change host dynamics, is important to
understand how this may impact transmission dynamics (Alonso et al., 1999; de
Roode et al., 2008; van den Hurk et al., 2012). The last part of my dissertation
examined the effect of vaccination on transmission in experiments where one
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pathogen infects the host before the other pathogen, with a fully factorial
experimental design.
Understanding how vaccines and genetic disease resistance affect
pathogen transmission and epidemiology will help to provide information for
vaccine development and selective breeding programs in order to better control
outbreaks in agricultural and wild systems. These results will also help us
understand how preventative methods impact transmission of the target and nontarget pathogen. Information from this study is relevant to other wildlife,
agriculture, and human disease systems in which vaccines and selective
breeding are being used that are not experimentally tractable, such as rabies in
raccoons and bacterial diseases in cows (Berry et al., 2011). This is particularly
relevant to aquaculture systems, as aquaculture is the fastest growing sector of
agriculture, yet infectious disease has hindered this growth (Kotob et al., 2017).
Additionally, because water from fish farms is not treated before it is released
into the environment, there is potential of transmitting pathogens from
aquaculture to wild populations. This could devastate wild salmonid populations,
many of which are threatened or endangered.
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Goals and Objectives
The overall goal of these studies was to determine the impact of
vaccination and genetically-bred disease resistance on transmission of IHNV and
Flavobacterium psychrophilum in rainbow trout. This was accomplished by
quantifying viral and bacterial particles shed from infected fish using molecular
techniques. Individual portions of this dissertation were designed to address the
following objectives:
Chapter 1.
Impact of vaccination and pathogen exposure dose on shedding kinetics
of infectious hematopoietic necrosis virus (IHNV) in rainbow trout
Chapter 2.
Effect of exposure dosage on shedding kinetics of Flavobacterium
psychrophilum in rainbow trout
Chapter 3.
Impact of co-infection on pathogen transmission of infectious
hematopoietic necrosis virus and Flavobacterium psychrophilum in
rainbow trout
Chapter 4.
Quantifying the impact of vaccination on transmission of IHNV and
Flavobacterium psychrophilum during simultaneous and sequential coinfection
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CHAPTER 1
Impact of vaccination and pathogen exposure dose on shedding kinetics
of infectious hematopoietic necrosis virus (IHNV) in rainbow trout
Darbi R. Jones1*, Barbara J. Rutan1, and Andrew R. Wargo1
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ABSTRACT
Globally, infectious diseases are responsible for major conservation and
economic losses in wild and farmed animal populations. Vaccination is used to
prevent mortality due to pathogens that cause such diseases, but how it impacts
transmission is rarely studied. In particular, vaccine impacts on transmission
under diverse field conditions, such as variable pathogen exposure dosages, is
not fully understood. In an attempt to fill these knowledge gaps, we evaluated the
impacts of vaccination on disease-induced mortality and transmission of
infectious hematopoietic necrosis virus (IHNV) in rainbow trout Oncorhynchus
mykiss. Fish were challenged with a range of virus dosages, in up to three
different fish genetic lines, to accurately reflect field variability. Mortality and viral
shedding of each fish was quantified over the course of infection. As the
challenge dosage increased, mortality, number of fish shedding virus, daily
amount of virus shed, and total amount of virus shed also increased. Vaccination
significantly reduced mortality, but had a much smaller impact on shedding, such
that vaccinated fish still shed significant amounts of virus, particularly at higher
viral exposure dosages. These studies demonstrate that consideration of
pathogen exposure dosage and transmission are critical for robust inference of
vaccine efficacy. This is likely to improve vaccine development and management
of pathogens, particularly those in aquaculture.
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1. INTRODUCTION
The rainbow trout (Oncorhynchus mykiss) is an important aquaculture
species worldwide (FAO Fishery Statistics 2016). The USA alone produced over
26,300 metric tons of food-grade trout in 2015 (USDA 2016). Infectious disease
has been and continues to be a major problem in rainbow trout aquaculture
(Meyer 1991; Roberts and Shepherd 1974; Lafferty et al. 2015; LaPatra et al.
1994). Vaccinations are an effective strategy for managing a variety of diseases
in trout aquaculture (Leong and Fryer 1993; Kurath 2008; Rogers and Basurco
2009; Sommerset et al. 2005); however, there are many trout pathogens for
which vaccines have proven ineffective or are not available. Furthermore,
although many vaccines have been investigated for how well they protect against
clinical disease (Adelmann et al. 2008; Cain and Zinn 2011; de las Heras et al.
2010; LaFrentz and LaPatra 2003; Kurath 2008), very little is known about how
they impact pathogen transmission.
Evidence from a variety of systems indicates that many disease-reducing
vaccines may protect poorly against transmission. For example, transmission
from vaccinated hosts to unvaccinated hosts was documented in vaccinated
baboons exposed to Pertussis (Warfel et al. 2014), in Atlantic salmon exposed to
infectious hematopoietic necrosis virus (Long et al. 2017), and in case-control
studies using live attenuated oral polio vaccines (Sutter et al. 1991). Additionally,
protection under diverse conditions commonly observed in the field, such as
variable pathogen exposure dosages, is not fully understood (Langwig et al.
2019). Recent studies have indicated that vaccine efficacy is pathogen dose
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dependent, particularly in the context of transmission blocking (Gomes et al.
2014; Langwig et al. 2017). Therefore, typical single dose vaccine trials may not
accurately predict vaccine efficacy in the field. In particular, long term or repeated
exposures in the field may overwhelm vaccine protection against disease and
transmission. If vaccinated individuals allow for transmission, it could result in
persistence of a pathogen, particularly in areas where vaccine coverage is poor.
This may prove a challenge to pathogen eradication (Meyns et al. 2006; Van der
Goot et al. 2007; Gandon et al. 2003) and influence the potential evolutionary
responses of pathogens to vaccination, such as the evolution of increased
virulence (Gandon et al. 2001; Lipsitch and Moxon 1997). Ultimately, the poor
understanding of vaccine impacts on transmission has greatly hindered the ability
to make reliable predictions of vaccine efficacy and likely plays a role in vaccine
failures observed in the field (Lavine et al. 2010).
In rainbow trout aquaculture, one of the leading pathogens is infectious
hematopoietic necrosis virus (IHNV). IHNV is a single-stranded, negative-sense
RNA virus of the Rhabdoviradae family (Bootland and Leong 1999). This
pathogen is endemic to salmonid species along the Pacific coast of North
America, but can now be found worldwide where trout aquaculture occurs (Hill
1992; Sano et al. 1977; Dixon et al. 2016; OIE 2009). IHNV causes an acute
disease that results in epidemics in trout farms and hatcheries (Troyer et al.
2000) with up to 100% mortality (Bootland and Leong 1999). The virus is
transmitted horizontally through the water via bodily fluids, carcass degradation,
or by cohabitation with infected fish (Amend 1975; Traxler et al. 1993). High
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mortality due to IHNV in aquaculture settings causes extreme economic loss to
the industry. As such, vaccines against IHNV have been created to manage the
spread of the pathogen. One of the most effective is a DNA vaccine developed
by Corbeil et al. (1999), which has been shown to reduce salmonid mortality by
up to 100% (Garver et al. 2005; Corbeil et al. 2000a; Corbeil et al. 2000b). This
vaccine is used widely in Canadian Atlantic salmon (Salmo salar) farming (Wade
2017) and was recently commercialized by Novartis and approved by the United
States Department of Agriculture (USDA), for use in USA aquaculture (USDA
2013; Garver and Wade 2017). Despite its successes in controlling disease, little
is known about how this vaccine impacts pathogen transmission, particularly
under field conditions. A study published by Long et al. (2017) showed that
transmission of IHNV in vaccinated individuals was possible in Atlantic salmon.
However, rainbow trout have a different susceptibility to and evolutionary history
with IHNV than Atlantic salmon (LaPatra 1998). Furthermore, the viral shedding
kinetics of the two fish species in the absence of vaccination have been shown to
be distinct (Wargo et al. 2017; Garver et al. 2013), and, therefore, are likely to be
differentially impacted by vaccination.
In this study, we investigated the impact of vaccination on transmission of
IHNV in rainbow trout (Oncorhynchus mykiss) across a range of viral challenge
dosages to accurately reflect field variability. Transmission has been linked to
viral shedding from the host into the water (Doumayrou et al. 2019); therefore
shedding was used as a proxy for transmission. Although shedding kinetics have
been characterized in this system (Wargo et al. 2017), the effects of viral
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exposure dosage and vaccination on these kinetics has yet to be shown. To
increase the field relevance and generalizability of the study, we also
investigated vaccine impacts on viral shedding kinetics in three major, genetically
distinct trout lines used in aquaculture. Multiple fish lines are used in aquaculture
and studies have indicated that fish populations may differ immunogenetically
and respond differently to vaccination (Overturf et al. 2003). This study is
directed towards increasing the ability to infer IHNV vaccine efficacy in the field.
In particular, this study will provide information on the efficiency of the vaccine to
block transmission, which is critical for pathogen management.
2. METHODS
2.1 Fish lines
Three rainbow trout fish lines were used in the experiments, designated
IHNV.R, ARS-Fp-R, and ARS-Fp-S, to reflect genetic diversity that would be
found in aquaculture. Line IHNV.R was obtained from Clear Food Springs, Inc.
and has been selected for a variety of aquaculture production enhancing traits
such as growth and resistance to IHNV as well as other diseases (LaPatra and
Towner 2006). Line ARS-Fp-R was bred exclusively for five generations to be
genetically resistant to Flavobacterium psychrophilum, agent of bacterial cold
water disease (BCWD), by the National Center for Cool and Cold Water
Aquaculture (NCCCWA), USDA ARS Facility in West Virginia. Line ARS-Fp-S
originated from the same ancestor as line ARS-Fp-R, but was bred for one
generation to be susceptible to BCWD, and then randomly outbred to maintain
susceptibility (Wiens et al. 2013). Fish lines IHNV.R, ARS-Fp-R, and ARS-Fp-S
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were used for experiment 1, while only IHNV.R and ARS-Fp-R were used for
experiment 2.
2.2 Virus
The pathogen used for the experiments was infectious hematopoietic
necrosis virus (IHNV, species: Salmonid novirhabdovirus) genotype C (genbank
accession number: AF237984). This genotype is part of the M genogroup and
was first isolated in the Idaho trout aquaculture region (Kurath et al. 2003). For
these studies, a new virus stock was propagated by passing a previous virus
stock on Epithelioma Papulosum Cyprini (EPC) cells (Fijan et al. 1983), and the
culture was then stored at -80ºC in Eagle’s minimum essential media (MEM;
Gibco) supplemented with 10% fetal bovine serum, as previously described
(Peñaranda et al. 2011). This virus stock was titered by triplicate plaque assays
(Batts and Winton 1989) and found to have a concentration of 7.56 x 108 plaque
forming units (PFU)/mL.
2.3 Vaccine
The vaccine used in this study was the DNA vaccine pWg containing the
glycoprotein gene (G) of IHNV genotype WRAC, and propagated using plasmid
Gigaprep kits (Qiagen) from the original transfected bacteria (Corbeil et al. 1999;
Corbeil et al. 2000a). This vaccine is heterologous to the virus challenge strain,
IHNV genotype C, used in this study. The vaccine provides highly efficient
disease protection as previously characterized (Corbeil et al. 2000a; Garver et al.
2005; LaPatra et al. 2001). Fish from each line were vaccinated with an
intramuscular injection of 0.05mg of the vaccine in 25µL of phosphate buffered
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saline (PBS) or sham vaccinated with 25µL PBS. Fish were then placed in 6L
tanks and held at 15ºC for 30 days to allow acquired immunity to develop
(Corbeil et al. 2000a).
2.4 Virus exposure and shedding sampling
Thirty days post-vaccination, fish were exposed to one of five dosages of
IHNV in batches grouped by treatment (10 fish per treatment experiment 1, 20
fish per treatment experiment 2) by placing them into 1L of static water
containing virus, for one hour. Exposures were estimated at 1 x 101, 1 x 102, 1 x
103, 1 x 104, and 1 x 105 pfu virus/mL water in Experiment 1 and 1 x 103, 1 x 104,
to 1 x 105, and 1 x 106 pfu virus/mL water for Experiment 2. Higher dosages
were used in experiment 2 because few fish were infected at the lower dosages
in experiment 1, which hindered elucidation of the shedding kinetics and vaccine
effects. Both experiments also contained a mock group exposed to the cell
culture medium: MEM + 10% fetal bovine serum (Gibco). After exposure, fish
were transferred to 6L tanks and washed at a flow rate of 1500-1600mL/min for
one hour to remove exposure virus. The fish were then individually separated
into randomly assigned 0.8L tanks in a tower rack system (Aquatic Ecosystems),
with water flow set to 150 ml/min. After all fish were distributed (approximately
two hours), water flow was turned off and a 1ml water sample was taken from
each tank (Day 0) and stored in a labeled 1.5 mL polypropylene microcentrifuge
tube. The tanks were then held static for 22 hours, after which time 1ml of water
was again sampled from each tank (Day 1). Holding the water static allowed for
an estimation of the accumulation of the total amount of virus shed over the
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previous 22 hour period. Water flow was turned back on to 150mL/min for a twohour wash to ensure all virus was removed from the tank (data not shown). This
sampling and wash cycle was repeated for Days 0-7. After sampling on Day 7,
tanks were flushed for two hours and then flow was set to 80 mL/min. Water was
then turned off to all tanks 22 hours before sampling on Day 10. Samples were
taken until Day 10 in experiment 1 and Day 7 in experiment 2. Mortality was also
tracked for 30 days. Water samples were stored at -80ºC for further processing.
The sampling process allowed us to quantify the total amount of virus each fish
shed per day. Water temperature was maintained at 15ºC ± 1C and fish were
provided with oxygen via air stones throughout the experiment. Fish were not fed
the day before the experiment or on Day 0. Fish were then fed Monday,
Wednesday, and Friday during the experiment. Over the 30-day course of the
experiment, 42 fish died in experiment 1 and 56 in experiment 2; however, dead
fish were left in their tanks and their water sampled as described above. At the
end of the experiment, all of the remaining fish were euthanized with an overdose
of 0.27 mg/ml tricaine methanesulfonate buffered with 0.09 mg/ml sodium
bicarbonate. All fish experiments were approved by the William and Mary IACUC
under protocol number IACUC-2014-06-17-9666-arwargo.
2.5 Sample Processing
RNA was extracted from 210µL of the water samples using the cador
Pathogen 96 Qiacube HT Kit (Qiagen) with a Tecan Freedom Evo 100 liquid
handling robot, as per manufacturer guidelines with the following modifications.
Each 210µl water sample was transferred from the 1.5mL microcentrifuge tube to
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a 96-well 2mL deep lysis plate. A mixture of 105µL of VXL, carrier RNA, and
Proteinase K was added to each sample (volume per sample: 84 µL VXL, 1 µL
carrier RNA, 20 µL Proteinase K), after which, the samples were vortexed for 30
seconds at 1800 rpm and allowed to incubate at room temperature for five
minutes. The samples were vortexed again for 30 seconds at 1800 rpm before
310µL ACB buffer was added. The samples were then vortexed for another 30
seconds at 1800 rpm and transferred to a nucleic acid-binding filter plate. They
were pulled into the filter membrane using a vacuum manifold at 250 mbar for
180 seconds. Each sample was washed with 600 µL of Buffer AW1 eluted at
350 mbar for 180 seconds. The samples were then washed with 600 µL of Buffer
AW2 eluted at 350 mbar for 60 seconds. Subsequently, the samples were then
washed with 700µL of 100% ethanol eluted at 350 mbar for 30 seconds. Finally
the samples were dried two times (700 mbar for 30 seconds followed by 350
mbar for 120 seconds) under vacuum. A 100µL volume of AVE buffer was then
added to the filter plate and allowed to sit for 120 seconds. The RNA was then
eluted into elution plate using the vacuum manifold at 700 mbar for 360 seconds.
All extracted RNA was stored at -80°C until further processing. RNA samples
were converted to cDNA using oligo (dT) random primers and Moloney murine
leukemia virus (M-MLV) reverse transcriptase (Promega), with 11uL of sample in
a 20uL reaction volume, as previously described (Wargo et al. 2010). For
quantification of viral RNA, cDNA was diluted 1:2, then processed using forward
and reverse primers IHNV N 796F, IHNV N 875R (Life Technologies), Taqman
probe IHNV N 818MGB ( Life Technologies), Taqman Universal PCR Master Mix
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No AmpErase UNG (Life Technologies) and artificial positive control (APC) DNA
plasmid transcript standards on a QuantStudio6 qPCR machine as described
elsewhere (Purcell et al. 2013). Since the qPCR assay specifically detects the
IHNV N gene and the vaccine only contains the G gene, only the quantity of virus
shed and not the vaccine was quantified. The qPCR assay provides the number
of viral RNA copies in water samples presented as virus copies per mL of water.
2.6 Statistics
Statistical analyses were carried out in R, version 3.2.2 (R Core Team
2015) and RStudio, version 1.1.423 (RStudio Team 2015). For all analyses,
assumptions of homogeneity of variance and normality were tested with residual
plots, Levene’s tests, and Shapiro-Wilk tests, where appropriate. Minimal models
were chosen by comparing model fits using AIC values, with differences greater
than 2 considered significant. Under the assumption of parsimony, the simplest
model that converged, with equal or lower AIC, was chosen. Of the 3240
samples that were processed in experiment 1, only 4 samples tested positive out
of the 900 negative controls (fish not exposed to virus) which indicates a false
positive rate of 0.44%. Of the 3200 samples that were processed in experiment
2, only 11 samples tested positive out of 1040 negative controls, which indicates
a false positive rate at 1.06%. In order to correct for the false positive rate, we
took an average of the negative control values and subtracted it from all of the
other sample values. This did not change any of the models or statistical results,
so the uncorrected results were presented.
2.6.1 Survival
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Survival was visualized using Kaplan Meier Analysis with the survfit
function in the Survival package in R. A few fish (12 in experiment 1 and 4 in
experiment 2) escaped from their tanks before the end of the experiment and
were censored from the day of escape forward. Analyses for all fish in
experiment 1 and unvaccinated fish in experiment 2 were done using Cox
proportional hazard models in R with the coxph function in the Survival package
(Therneau 2015). Explanatory fixed factors in the models were vaccine, fish line,
and log10 (dosage), which was a continuous variable. Their interactions were also
included. The baseline was set to the ARS-Fp-R, unvaccinated, fish treatment.
Due to lack of mortality for any of the vaccinated fish in experiment 2, the coxph
models were not able to converge. Therefore, a Log-Rank test with the survdiff
function was used to compare the survival of vaccinated versus unvaccinated
fish in experiment 2, pooled across all dosages and fish lines. Relative percent
survival (RPS) was calculated for both experiments using the formula: RPS = (1% mortality of vaccinated individuals/ % mortality of unvaccinated individuals) x
100.
2.6.2. Number of fish shedding per day
Number of fish shedding was analyzed with a logistic regression. The
response variable in the model was the proportion of a fish shedding per day as
indicated by a positive water sample. Day 0 and the negative control dosage
were not included in the model because our goal was to determining if shedding
differed between treatments from the point shedding began. Explanatory fixed
factors in each of the models were vaccine, fish line, log10 (dosage), and day,

30

with interactions included. A unique identifier for each fish (Fish ID) nested in day
was included in the model as a random factor, because the same fish were
sampled at multiple time points (repeated measures). Data was analyzed using
the glmer function in lme4 package (Bates et al. 2015) in R, with a binomial data
structure. The baseline model was represented by the unvaccinated, ARS-Fp-R
fish treatment.
2.6.3 Quantity of virus shed per day
Daily quantity of virus shed was analyzed with mixed effects models in R
with the lme function in the nlme packages (Pinheiro et al. 2015). The response
variable in the model was log10 + 1 transformed RNA copies of IHNV per mL.
Explanatory fixed factors were vaccine, fish line, log10 (dosage), and day. To
avoid over-parameterizing of the model only investigations of main effects and
two-way interactions were possible given the number of positive replicate
samples per treatment. Fish ID nested in day was included in the model as a
random factor, because each fish was sampled at multiple time points (repeated
measures). Maximum likelihood estimation of parameters was used due to its
ability to allow for model selection and to handle samples size of less than 30 per
treatment. Water samples with no detectable virus were dropped from the
analysis because our goal was to determine if the amount of shedding differed
between treatments for fish that were actively shedding virus. To ensure
adequate statistical replication, this analysis was conducted for Days 1-7 and
dosages 103, 104, and 105 pfu/ml for experiment 1, with the addition of dosage
106 pfu/ml for experiment 2, because of insufficient replicate positive samples at
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other dosages and time points. Thus, this analysis compares the rate of shedding
between fish during the peak shedding period. The baseline model was
represented by the unvaccinated, ARS-Fp-R fish treatment.
2.6.4 Total virus shed
Total virus shed was analyzed using a negative binomial regression with
the glm.nb function in the MASS package in R (Venabeles and Ripley 2002).
The response variable was the amount of virus shed by each individual fish per
day totaled over all days of the experiment and then log transformed.
Explanatory fixed factors were vaccine, fish line, and log10 (dosage). Their
interactions were also included. The negative control treatment was dropped
from the analysis, because we were interested in comparing vaccine and
dosages impacts on shedding between fish exposed to virus. However, fish
exposed to virus that did not shed were included. The baseline model was
represented by the unvaccinated, ARS-Fp-R fish treatment.
3. RESULTS
3.1 Survival
Mortality began around Day 7 and tapered off by Day 25, in all
experiments (Figure 1). For experiment 1, survivorship data fit the best to a cox
proportional hazard model including main effects of the factors vaccine, log10
(dosage), fish line, and day, as well as an interaction between vaccine and
dosage, (Supplemental Table 1). For experiment 2, vaccination reduced
mortality to zero across all virus dosages and fish lines. This reduction in
mortality was significant when compared to the levels observed in unvaccinated
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fish, after pooling across exposure dosage and fish line (Log rank test, 2= 66,
N=200, P-value<0.0001). Survivorship analysis of the unvaccinated fish in
experiment 2 revealed that the best fit model included main effects of the factors
fish line and log10 (dosage) (Supplemental Table 2). In both experiments as virus
exposure dosage increased, the hazard of death also significantly increased in
unvaccinated fish (P-value <0.05; Supplemental Table 1 and 2). In vaccinated
fish, this rate of increase was reduced by 34% in experiment 1 and did not occur
in experiment 2 because mortality remained 0 even at high viral exposure
dosages where mortality reached up to 60% in unvaccinated fish. As such,
vaccination reduced the risk of mortality in both experiments, and the effect was
more pronounced at the higher compared to lower virus exposure dosages in
experiment 1 (RPS Exp.1=50% ± 50% at the lowest dosage, 77.67 ± 14.68% at
the highest dosage, RPS Exp. 2 = 100% at all dosages). Fish mortality was
minimal at the lowest dosages in experiment 1, even in unvaccinated fish,
diminishing the possible effect of vaccination. A fish line effect was also
observed as expected, such that the IHNV.R fish line had 63% and 52% lower
hazards of dying in experiments 1 and 2 respectively, compared to the ARS-Fp-R
line (P-value <0.05; Supplemental Table 1 and 2). This occurred in all treatments
in experiment 1 and only unvaccinated fish in experiment 2, because mortality
was zero for the vaccinated fish in both fish lines in experiment 2. None of the
unexposed control fish died in experiment 2 and a low level mortality of control
fish was observed in experiment 1 that did not affect the results.
3.2 Number of fish shedding per day
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In general, the number of fish shedding peaked on Day 2 and then rapidly
tapered off (figure 2). The timing of shedding was highly consistent across
treatments, such that more than 90% of the fish started shedding by Day 2 and
more than 80% stopped shedding by Day 7, in both experiments. The logistic
regression model that best fit the number of fish shedding data from experiment
1 included main effects of fixed factors vaccine, log10 (dosage), fish line, and day
as well as interactions between vaccine and day, vaccine and fish line, and day
and log10 (dosage) (Supplemental Table 3). For experiment 2, the best fit model
included main effects of fixed factors vaccine, log10 (dosage), fish line, day, and
day2 as well as interactions between vaccine and day, and fish line and log10
(dosage) (Supplemental Table 4). Including the random factors, day and fish ID,
did not improve model fit for either experiment. The analysis revealed that as
challenge dosage increased, the probability of shedding also increased (P-value
<0.0001; Supplemental Table 3 and 4), such that very few fish shed at the lowest
dosages and all shed at the highest dosages, in both experiments (Figure 2).
For experiment 2, this relationship differed between fish lines, such that the rate
of increase was lower for the IHNV.R fish line (P-value= 0.37, Supplemental table
4). For experiment 1, the relationship between the probability of shedding and
dosage depended on day (P-value <0.0001; supplemental table 3), in that at the
lower dosages the probability of shedding remained 0 through time, whereas as
at the highest dosage it decreased from nearly 1 to 0 though time (Supplemental
Figure 1a). For experiment 2, the probability of shedding the virus initially
increased and then began to decrease over time (P-value <0.0001;
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Supplemental Table 4). However, the shape of this relationship was consistent
across dosages (Supplemental Figure 1b). In experiment 1, there was a general
reduction in the probability of shedding across all fish lines due to vaccination,
but this difference was only significant for the ARS-Fp-S fish line(P-value <0.001
Supplemental Table 3 and Supplemental Figure 2). There was also a greater
reduction in the probability of shedding due to vaccination at early time points
compared to later time points (P-value <0.001 Supplemental table 3 and
Supplemental Figure 3a). This is because at later time points the probability of
shedding was zero in experiment 1, regardless of vaccine treatment, so a
vaccine effect was not possible. In contrast, the probability of shedding
decreased more rapidly through time in vaccinated compared to unvaccinated
fish in experiment 2 (Supplemental Figure 3b). This resulted in no difference in
the probability of shedding between vaccinated and unvaccinated fish at early
time points, but a significantly lower probability in vaccinated fish at later time
points (p < 0.001, Supplemental table 4).
3.3 Quantity of virus shed per day
In general, the amount of virus shed was variable through time and
depended on viral exposure dosage and vaccination (Supplemental Figure 4). In
an effort to compare viral shedding rate, the daily amount of virus shed was
analyzed for only those fish shedding detectable virus (see Methods). The model
that best fit experiment 1 data included main effects of the factors vaccine,
log10(dosage), fish line, day, and day2; as well as an interaction between day
and fish line, and a random term of fish nested in day (Supplemental Table 5).
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The model that best fit experiment 2 differed only by the inclusion of interaction
between day and log10 (dosage), and log10 (dosage) and fish line; and exclusion
of the day and fish line interaction as well as day from the random term
(Supplemental Table 6). The best fit correlation structures for the models were
unstructured and autoregressive order 1 covariance matrixes for experiment 1
and 2, respectively. For both experiments, as viral exposure dosage increased, in
general, the amount of virus shed also significantly increased (P-value <0.001;
Supplemental tables 5 and 6; Supplemental Figure 5). For experiment 1, the
shedding rate rapidly increased until Day 4 and then began to taper across all
dosages (Figure 3a). In experiment 2 the shedding rate slightly increased or
remained stable through time at the lowest dosages and decreased through time
at the highest dosages (Figure 3b). Vaccination significantly decreased the rate
of viral shedding (P-value< 0.001; Supplemental Tables 5 and 6) across all
treatments in both experiments (Supplemental Figure 6), but did not completely
eliminate shedding. Despite these trends, there was no significant difference in
the amount of virus shed between the fish lines across dosages or through time
(Supplemental Figure 7).
3.4 Total virus shed
In an effort to compare absolute viral fitness between treatments, the total
amount of virus shed by each fish was analyzed. A negative binomial model
including the main effects of factors vaccination, log dosage, and fish line, best fit
the experiment 1 data (Supplemental Table 7). The best fit model for experiment
2 only differed by the addition of an interaction term between vaccine and log10
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(dosage) (Supplemental Table 8). The analysis for both experiments indicated
that the total amount of virus shed increased with increasing dosage (Figure 4, Pvalue <0.0001; Supplemental Tables 7 and 8). For experiment 1, there was a
significantly higher amount of virus shed by unvaccinated fish compared to
vaccinated fish, across all treatments (Figure 4a, P-value <0.0001; Supplemental
table 7). For experiment 2, the amount by which vaccination reduced the total
amount shed decreased as dosage increased, but remained significant across all
dosages (Figure 4b, P-value <0.05; Supplemental Table 8). Despite suggestive
trends, no significant difference was observed between the fish lines in the total
amount of virus shed for either experiment (Supplemental Table 7 and 8).
4. DISCUSSION
This is one of the first studies to investigate vaccine impacts on host
mortality and virus shedding kinetics, across multiple pathogen exposure
dosages and host lineages. The study provided an estimate of the efficacy of
blocking transmission using vaccination under simulated variability in dosage. In
general, the IHNV DNA vaccine investigated protected well against mortality, with
relative percent survival being 50-100% when comparing vaccinated and
unvaccinated fish across all conditions tested. This was even true at high
pathogen exposure dosages, despite increased mortality in unvaccinated groups.
These findings are in line with other studies investigating the disease prevention
efficacy of this vaccine (Corbeil et al. 2000b; Garver et al. 2005; Kurath 2008).
The vaccine was much less effective at blocking transmission, as the majority of
vaccinated fish still became infected and shed virus. In addition to bolstering
inference of efficacy in the field, quantification of shedding kinetics across
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multiple virus exposure dosages provided insights into possible mechanisms of
vaccine protection.
The reduction in mortality due to vaccination appeared to be partly driven
by a significant reduction in the probability of fish becoming infected, suggesting
that the vaccine exhibited infection blocking properties. However, large numbers
of vaccinated fish still became infected and shed virus, particularly at higher viral
challenge dosages. Furthermore, reductions in mortality due to vaccination were
greater than reductions in infection suggesting that the vaccine was only partially
successful in blocking transmission to other fish, and that this was not the only
mechanism by which the vaccine reduced mortality.
Additionally, vaccination also reduced the overall rate of virus shedding by
infected fish through time, resulting in the total amount of virus shed being less in
vaccinated versus unvaccinated fish. This indicates that vaccinated fish also
have reduced within-host viral loads (Wargo and Kurath 2011). This appears to
be driven by reductions in peak shedding as well as more rapid viral clearance in
vaccinated compared to unvaccinated fish. This was most pronounced in
experiment 2, likely because the lowest three doses in experiment 1 caused very
little infection in unvaccinated fish, so a vaccine effect could not be observed.
These findings are in line with others that have found vaccination expedites
pathogen clearance (Coward et al. 2014; De Jong and Kimman 1994). Again,
these reductions were not absolute, in that vaccinated fish still shed a significant
amount of virus that was capable of transmission to new hosts. Likewise, small
or insignificant reductions in shedding were often observed when mortality was
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reduced to zero. The bulk of this shedding occurred during Days 1-4, where
vaccine effects on shedding were even less pronounced. Therefore, viral load
reductions can only partially explain vaccine disease protection.
Collectively, these results indicate that the mechanism by which the pWg
vaccine operates may involve both resistance and tolerance (Råberg et al. 2007).
The vaccine appeared to make hosts more resistant by reducing the number of
hosts infected, peak viral loads within hosts, and duration of viremia. However,
the changes in infection levels were relatively small compared to those in
survival, suggesting a tolerance mechanism was equally if not more important.
This tolerance mechanism allowed for the increased survival of fish, even at the
same viral load levels. These results are similar to a study where fish vaccinated
against Enteric Red Mouth disease were exposed to Yersinia ruckeri; although
the vaccine prevented mortality, the bacterial burdens in the spleen were the
same for both vaccinated and unvaccinated fish (Harun et al. 2011).
Immunologically, the mechanisms responsible for vaccine reductions in
disease susceptibility are believed to be associated with the interferon response.
When vaccinated with pWg, there is an up-regulation of Mx-1 and Vig-8 in trout
(Purcell et al. 2004; Purcell et al. 2006). This is the first line of host defense
against RNA viruses and indicates that early non-specific type I interferon antiviral response is important in stimulating the adaptive immunity against IHNV
(Verhelst et al. 2014). Peñaranda et al. (2009) showed that when trout are
challenged with IHNV, Mx-1 was up-regulated on Day 1, peaked on Day 3 and
remained high until after Day 7. This, in general, followed the shedding kinetics
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here in that shedding peaked around Days 1-3 and then began to decline.
Collectively, this suggests that the up-regulation of Mx-1 due to vaccination leads
to more rapid viral clearance, and ultimately reduced mortality. There is also
evidence that this primed interferon response provides some, but not absolute,
protection against infection and partially blocks viral replication (Park et al. 2011).
However, the immune response in vaccinated fish appears to be more effective
at managing disease even when viral loads remain high. This tolerance may be
due to better regulation of immunopathology similar to that of Chinook salmon
exposed to Renibacterium salmoninarum (Metzger et al. 2010). This warrants
further investigation.
Pathogen exposure dosage had a large impact on mortality and shedding,
which ultimately shaped vaccine efficacy. As dosage increased, mortality,
probability of infection, and total amount of viral shedding also increased
commensurately. Vaccination appeared to attenuate this dosage effect, such that
the increase in shedding with increasing dosage was reduced in vaccinated fish
compared to unvaccinated fish. However, when analyzing the total amount of
virus shed over the entire experiment, there was evidence that at very high
dosages, prevention of shedding by vaccination, and, to some extent, efficacy in
blocking mortality and infection was reduced. This suggests that at very high viral
dosages, immunity provided by vaccination is overwhelmed. These findings
agree with the findings of others that increasing pathogen dose leads to
increased infection probability and reduced vaccine efficacy, although studies are
limited and the shape of the relationship varies between systems (Langwig et al.
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2017; Langwig et al. 2019; Gomes et al. 2014). There are ongoing investigations
into whether the increase in probability of infection with pathogen exposure dose
is a function of simply more virus particles entering the host (independent action)
or virus particles interacting in some way to enhance infection (mass action) such
as through suppression or overwhelming of the immune system (Zwart et al.
2011; Regoes et al. 2003). Previous studies in this system indicate an
independent action mechanism, in that the increased probability of infection with
dose is not greater than expected due to simply a larger number of infectious
particles being present (McKenney et al. 2016). However, these previous studies
did not examine the duration of shedding, which could provide some insights into
the nature of protection.
Our results show that the duration of viral shedding was not dosage
dependent. For all dosages, peak shedding occurred between Days 2-4 and
shedding largely stopped by Day 10, as found by Wargo et al. (2017). Mortality,
on the other hand, began around Day 5, well after the majority of virus was shed,
but again the kinetics were consistent across dosages. The impact of dosage on
infection kinetics is variable. Some studies suggest that lower dosages may lead
to prolonged infection due to delayed immune stimulation, while others indicate
that higher dosages may result in longer infection durations because they
overwhelm the immune system (Li and Handel 2014). Because dosage
increased the initial probability, but not duration, of shedding this implies immune
clearance of the infection by fish operated at the same rate regardless of dose.
This suggests that increasing dosage did not lead to suppression of the immune
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system and supports the independent action hypothesis of virus particles, as
previously observed by McKenney et al (2016). However, the results imply that
vaccine protection may operate under a threshold, wherein high viral dosages
will overwhelm reductions in the probability of infection due to vaccination, and
that these reductions are not absolute. This has been seen in other systems
(Langwig et al. 2019) and could be a function of limits in the level of immune
stimulation that vaccination can provide, such as through antibody production.
Examining vaccine efficacy at multiple vaccine dosages may shed light on this.
Fish line had some effect on shedding kinetics and vaccine protection,
highlighting the importance of fish background when inferring vaccine efficacy in
the field. There was evidence that the IHNV.R fish had lower disease
susceptibility, in that mortality levels were reduced in this fish line. These results
are not surprising given the history of the IHNV.R line having been selectively
bred against IHNV disease. This appears to operate through both a resistance
and tolerance mechanism. Resistance was evident in the finding that the
probability of infection did not increase as quickly for the IHNV.R line with virus
exposure dosage, compared to the other fish lines. Yet this effect was small, and
high numbers of IHNV.R fish became infected, despite reduced levels of
mortality, indicating tolerance may be stronger than resistance. This suggests
that selective breeding and vaccination may operate by the same mechanism.
There was also an indication that the ARS-Fp-S fish line responded better to
vaccination than the other fish lines although the mechanism is unclear. Selective
breeding of the IHNV.R and ARS-Fp-R lines may have reduced their immune
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competence, such that vaccination elicited a smaller immune response in those
fish, compared to the ARs-Fp-S line, which had not undergone selective
breeding. Indeed, host immunity to one pathogen can have tradeoffs with
susceptibility to another (Alcivar-Warren et al. 1997; Ehlinger 1977). However,
this would imply the ARS-Fp-R would respond poorly to vaccination against IHNV
than the IHNV.R line, which was not the case. Furthermore, the increased
response of the ARS-Fp-S line was only observed towards infection and not
mortality. Perhaps selective breeding results in reduced antibody diversity in fish,
and thus reduces vaccine competence (Sommer 2005; Spielman et al. 2007). If
true, this would have major implications for disease management across
agriculture.
In summary, our results indicated that vaccine efficacy is dependent on
pathogen exposure dosage and fish line. Additionally, it was observed that the
vaccine was highly effective at preventing disease, but did not block infection nor
limit viral shedding. This effect was particularly pronounced at higher pathogen
exposure dosages. Overall, vaccination reduced pathogen fitness by an order of
magnitude or less (reduction in total shedding). If viral shedding is correlated with
transmission, as other studies have suggested (Wargo and Kurath 2012), this
would imply vaccinated hosts are still able to transmit the virus, despite
experiencing little clinical disease. Epidemiologically, the ability of vaccinated
individuals to transmit the disease could greatly hinder management and
eradication of disease, particularly if there is transmission between vaccinated
and unvaccinated fish, such as can occur between wild and aquaculture
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populations (Troyer and Kurath 2003). There are also potential long-term
evolutionary consequences such as the selection for increased pathogen
virulence (Mackinnon et al. 2008; Gandon et al. 2001). Evidence of vaccine
induced virulence has been observed in Marek’s disease virus (Nair 2005; Read
et al. 2015; Atkins et al. 2013; Davison and Nair 2004). Whether this could occur
in the IHNV system warrants further investigation. However, vaccines such as
the one used in the present study, which reduce clinical disease but allow
transmission, are of particularly concern.
This study illustrates the importance of considering challenge dosage,
infection, and transmission when evaluating vaccine efficacy. The development
of vaccines that prevent transmission would be most beneficial. This could
improve disease management in vaccinated and unvaccinated host populations
by increasing herd immunity (Metcalf et al. 2015). A transmission blocking
vaccine would also alleviate the potential risk of vaccine-induced selection for
virulence (Gandon et al. 2001). A variety of IHNV vaccines, as well as other fish
pathogen vaccines, are available or currently in development (Sommerset et al.
2005). However, the transmission blocking efficacy of these vaccines under
common field conditions, such as variable pathogen dosages or fish lines, is
largely unknown. Many existing fish vaccines, particularly those delivered
through non-injection routes, such as immersion or through feed, have been
shown to have lower disease prevention efficacy compared to the DNA vaccine
studied here (Plant and LaPatra 2011; Kurath 2008). Whether this translates to
lower transmission blocking efficacy is unclear; however, if that is the case, it is
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likely to heavily impact their utility for disease management. Our results indicated
that selective breeding against IHNV may also act via a similar tolerance
mechanism as vaccination, where disease, but not infection levels or
transmission, is reduced. This would make the same potential concerns about
pathogen persistence and virulence evolution associated with vaccines also
applicable to selective breeding. Overall, this and future studies into vaccines or
control methods that block transmission are likely to facilitate the development,
evaluation, and efficacy of disease management programs.
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TABLES AND FIGURES

Figure 1. Survivorship of trout exposed to IHNV. Lines represent the KaplanMeier survivorship through time, of unvaccinated (dotted line) or vaccinated fish
(solid line), exposed to different dosages (pfu/ml) of virus (denoted by color). The
60

top three panels show experiment 1 for fish lines ARS-Fp-R (a), IHNV.R (b), and
ARS-Fp-S (c). The bottom two panels show experiment 2 for fish lines ARS-Fp-R
(d) and IHNV.R (e). Lines that are not visible had zero mortality (proportion
survival =1) and overlap.
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Figure 2. Number of fish shedding IHNV per day. Lines represent total number of
fish out of 10 (panels a-c) or 20 (panels d-e) that had detectable IHNV shedding
by qPCR, through time. Unvaccinated fish are represented by the dotted line,
and vaccinated fish are represented by the solid line. The color in the legend
represents the challenge dosage of virus in PFU/mL. The top three panels show
experiment 1 for fish lines ARS-Fp-R (a), IHNV.R (b), and ARS-Fp-S (c). The
bottom two panels show experiment 2 for fish lines ARS-Fp-R (d) and IHNV.R
(e). Points represent when samples were taken. Lines that are not visible had
zero fish shedding.
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Figure 3. Predicted quantity of virus shed through time. Lines represent best fit
linear trend of predicted daily amount of virus shed (Log10 (virus RNA copies/ml
H2O+1)) for various pathogen exposure dosages (pfu/ml), from statistical models
(described in methods), for experiment 1 (a) and 2 (b). The gray shading is the
95% confidence interval around the model fit line. The dots are fitted values for
individual fish. Some fish have the same predicted value and dots overlap.
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Figure 4. Predicted total amount of virus shed. Lines represent best fit linear
trend of predicted total amount of virus shed (Log10(virus RNA copies/ml H2O+1))
for various pathogen exposure dosages, from statistical models (described in
methods). Dots are predicted values for each fish; however some have the same
value, so they overlap. Black lines represent unvaccinated hosts while gray lines
represent vaccinated hosts. The gray shading is the 95% confidence interval
around the model fit line. Dosage is a continuous variable from 101 to 105
PFU/mL for experiment 1 (panel a) and from 103 to 106 PFU/mL for experiment 2
(panel b).
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Supplemental
1. Survival
Table 1. Experiment 1 Survival Model Output.
Model: coxph(Surv(Day.Dead, Censor="0") ~ Vaccine+Fish.Line+Dosage+ Vacci
ne*Dosage)
Confidence intervals and p-values by Wald Test (28.2 on 5 df, p=3.323 x10-5).
coef exp(coef) se(coef)
z
VaccineVax
0.2568
1.2928
0.7325 0.351
Fish.LineARS-Fp-S
0.3237
1.3822
0.3119 1.038
Fish.LineIHNV.R
-0.9983
0.3685
0.4455 -2.241
Dosage
0.2175
1.2429
0.1015 2.142
VaccineVax:Dosage -0.4231
0.6550
0.2026 -2.088
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1

Pr(>|z|)
0.7259
0.2994
0.0250 *
0.0322 *
0.0368 *

Table 2. Experiment 2 Unvaccinated Fish Survival Model Output
Model for Unvaccinated Fish: coxph(formula=Surv(Day.Dead, Censor=="0") ~
Fish.Line+Dosage)
Confidence intervals and P-values by Wald Test (39.52 on 2 df,
p-value=2.626x 10-9)
Coef se(coef) exp(coef)
z
P-value
Fish.LineIHNV.R
-0.7362
0.4789
0.2825 -2.606
0.00916*
Dosage
0.6491
1.9139
0.1133
5.732 9.95e-09***
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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2. Number of fish shedding per day
Table 3. Experiment 1 Number of fish shedding Model Output.
Model: glm(cbind(Number.for.pos.count,Number.for.neg.count)~ Vaccine+Day
+Fish.Line+Dosage+Vaccine*Day+ Vaccine*Fish.Line+ Day*Dosage,
family=binomial)
Null deviance: 2052.9 on 2240 degrees of freedom
Residual deviance: 1286.8 on 2231 degrees of freedom
Estimate Std. Error
(Intercept)
-6.5298
0.51466
VaccineVax
-0.0581
0.35857
Day
0.3503
0.09615
Fish.LineARS-Fp-S
1.0761
0.22776
Fish.LineIHNV.R
0.1466
0.23990
Dosage
1.8402
0.13087
VaccineVax:Day
-0.1292
0.07587
VaccineVax:Fish.LineARS-Fp-S -1.3225
0.36355
VaccineVax:Fish.LineIHNV.R
-0.0753
0.36459
Day:Dosage
-0.2093
0.02674
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1

z value
-12.688
-0.162
3.644
4.725
0.611
14.062
-1.703
-3.638
-0.207
-7.828

Pr(>|z|)
< 2e-16 ***
0.871179
0.000269 ***
2.30e-06 ***
0.541085
< 2.0e-16 ***
0.088612 .
0.000275 ***
0.836312
4.95e-15 ***

Table 4. Experiment 2 Number of fish shedding Model Output.
Model: glmer cbind(Number.for.pos.count, Number.for.neg.count) ~ Vaccine + Fi
sh.Line + Dosage + Day + Vaccine * Day + Fish.Line * Dosage + I(Day^2), famil
y = binomial)
Null deviance: 2808.7 on 2239 degrees of freedom
Residual deviance: 2076.8 on 2232 degrees of freedom
Estimate Std. Error z value
Pr(>|z|)
(Intercept)
-6.89677
0.47245 -14.598
< 2e-16 ***
VaccineVax
0.80077
0.25588
3.129
0.00175 **
Fish.LineIHNV.R
0.82656
0.49562
1.668
0.09537 .
Dosage
0.95130
0.07585 12.543
< 2e-16 ***
Day
1.81047
0.15440 11.726
< 2e-16 ***
I(Day^2)
-0.25316
0.01955 -12.950
< 2e-16 ***
VaccineVax:Day
-0.59664
0.07390
-8.074 6.82e-16 ***
Fish.LineIHNV.R:Dosage -0.21479
0.10273
-2.091
0.03654 *
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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Figure S1.Predicted likelihood of shedding through time. Lines represent best fit
linear trend of predicted daily likelihood of virus shedding, from statistical models
(described in methods), for each virus dosage (pfu/mL) in experiment 1 (panel a)
and 2 (panel b). The gray shading is the 95% confidence interval around the
model fit line. The dots are fitted values for individual fish; however some fish
have the same predicted value, so dots overlap.
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Figure 2. Interaction between fish line and vaccine treatment for likelihood of
virus shedding. Lines show predicted likelihood of viral shedding for each fish
line, and vaccine treatment (vaccinated = grey, unvaccinated = black), from
experiment 1. Values were obtained from generalized linear model of number of
fish shedding (Supplemental table 4).
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Figure 3. Predicted likelihood of shedding through time. Lines represent best fit
linear trend of predicted daily likelihood of virus shedding, from statistical models
(described in methods), for each vaccine in experiment 1 (a) and 2 (b). Black
lines represent unvaccinated hosts while gray lines represent vaccinated hosts.
The gray shading is the 95% confidence interval around the model fit line. The
dots are fitted values for individual vaccinated (gray) or unvaccinated (black) fish.
There are values for each fish, however some have the same value so they
overlap.
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3. Quantity of virus shed per day

Figure 4. Virus quantity shed per day. Lines show mean [log10(viral RNA
copies/ml H2O+1)], shed per day of fish exposed to different dosages (pfu/ml,
denoted by color) of IHNV. Panels a (ARS-Fp-R), b (IHNV.R), and c (ARS-Fp-S)
show experiment 1, while panels d (ARS-Fp-R) and e (IHNV.R) show experiment
2. Unvaccinated fish are represented by the dotted line, and vaccinated fish are
represented by the solid line. If no point is shown, all fish were negative. Only fish
actively shedding virus are included in the mean. Both live and dead fish were
included.
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Table 5. Experiment 1 Quantity of virus shed per day Model Output.
Model: lme(Log.Quantity~I(Day^2)+Day+Vaccine+Dosage+Fish.Line+Day:Fish.Li
ne, random=~Day|Tank.Number,+ method="ML", na.action="na.omit", weights=v
arExp(), correlation=corSymm())

(Intercept)
I(Day^2)
Day
VaccineVax
Dosage
Fish.LineARS-Fp-S
Fish.LineIHNV.R
Day:Fish.LineARS-Fp-S
Day:Fish.LineIHNV.R

Value
1.4921516
-0.043805
0.3153212
-0.329781
0.4462417
-0.019225
-0.236642
0.016974
0.037679

Std.Error
0.2019516
0.0113398
0.0976626
0.0635307
0.0112070
0.1415891
0.1417937
0.0673474
0.0691524

DF
197
197
197
134
134
134
134
197
197

t-value
7.38866
-3.86297
3.22868
-5.19090
39.8181
-0.13579
-1.66892
0.25204
0.54488

P-value
0.0000
0.0002
0.0015
0.0000
0.0000
0.8922
0.0975
0.8013
0.5865

Table 6. Experiment 2 Quantity of virus shed per day Model Output.
Model: lme(Log.Quantity~I(Day^2)+Day+Vaccine+Dosage+Fish.Line+Day:Dosag
e+Dosage:Fish.Line, random=~1|Tank.Number, + method="ML", na.action="na.o
mit", weights=varExp(), correlation=corAR1())

(Intercept)
I(Day^2)
Day
VaccineVax
Dosage
Fish.LineIHNV.R
Day:Dosage
Dosage:Fish.LineIHNV.R

Value
2.26482
0.03807
-0.05751
-0.23765
0.34288
-0.52762
-0.06490
0.10026

Std.Error
0.474098
0.012906
0.146085
0.081525
0.089718
0.364671
0.021339
0.074071
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DF
459
459
459
250
250
250
459
250

t-value
4.777112
2.950001
-0.393679
-2.915046
3.821743
-1.446843
-3.041604
1.353687

p-value
0.0000
0.0033
0.6940
0.0039
0.0002
0.1492
0.0025
0.1771

Figure 5. Predicted mean virus quantity across dosage. Lines show
mean[log10(viral RNA copies/mL H2O)], shed per fish exposed to different
dosages (pfu/mL), from statistical models (described in methods). The blue line
represents the model fit line. The gray shading is the 95% confidence interval
around the model fit line. The dots are predicted values for individual fish;
however some have the same value, so they overlap. Dosage is a continuous
variable from 101 to 105 PFU/mL for experiment 1 (a) and from 103 to 106
PFU/mL for experiment 2 (b).
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Figure 6. Predicted mean quantity shed. Bars represent best fit linear trend of
predicted mean amount shed for each vaccine treatment, from statistical models
(described in methods), for experiment 1 (a) and 2 (b). Error bars represent
mean ± standard deviation. Only positive fish for both experiment were included.
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Figure 7. Predicted quantity shed over time. Lines represent best fit linear trend
of predicted quantity shed for multiple fish lines across various dosages over
time, for experiment 1 (a) and 2 (b). Red lines represent ARS-Fp-R hosts, green
lines represent ARS-Fp-S hosts, and blue lines represent IHNV.R hosts. ARSFp-R and ARS-Fp-S are almost identical, so much so that it is very difficult to see
the red line representing ARS-Fp-R because it is beneath the green line
representing ARS-Fp-S. The gray shading is the 95% confidence interval around
the model fit line. The dots are predicted values for individual fish; however,
some fish have the same predicted value and dots overlap.
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4. Total virus shed
Table 7. Experiment 1 Total virus shed Model Output.
Model: glm(Quantity ~Vaccine + Fish.Line + Dosage, link=log)
Null deviance: 851.17 on 299 degrees of freedom
Residual deviance: 471.59 on 295 degrees of freedom
Estimate
Std. Error
(Intercept)
-1.11256
0.15496
VaccineVax
-0.35582
0.07968
Fish.LineARS-Fp-S
0.08401
0.09433
Fish.LineIHNV.R
-0.07607
0.09817
Dosage
0.57729
0.03369
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1

z value
-7.180
-4.466
0.891
-0.775
17.135

Pr(>|z|)
6.98e-13 ***
7.98e-06 ***
0.373
0.438
< 2e-16 ***

Table 8. Experiment 2 Total virus shed Model Output.
Model: glm(Quantity ~Vaccine + Fish.Line + Dosage + Vaccine*Dosage, link=log)
Null deviance: 489.26 on 318 degrees of freedom
Residual deviance: 330.98 on 314 degrees of freedom
Estimate
Std. Error
(Intercept)
-0.11999
0.20321
VaccineVax
-1.01462
0.31529
Fish.LineIHNV.R
-0.02225
0.06513
Dosage
0.28394
0.04038
VaccineVax:Dosage
0.15708
0.06229
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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z value
-0.590
-3.218
-0.342
7.032
2.522

Pr(>|z|)
0.55489
0.00129 **
0.73259
2.03e-12 ***
0.01168 *
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ABSTRACT
Flavobacterium psychrophilum, the causative agent of Bacterial Cold Water
Disease (BCWD), is one of the leading pathogens in rainbow trout aquaculture,
and can cause up to 70% mortality. To date, there is little knowledge of how
transmission of Flavobacterium psychrophilum changes over the course of the
infection. In particular, how transmission is affected by host genotype and
pathogen exposure dose is poorly understood. In order to fill in these gaps, we
exposed two genetically distinct lines of rainbow trout to a range of dosages of F.
psychrophilum, and then measured mortality and bacterial shedding, as a proxy
for transmission, over the course of the infection. As dosage increased, the
number of fish shedding and the number of bacteria shed into the water
increased. In addition, we found that disease resistance was not correlated with
the blocking of transmission, in that the majority of fish which shed bacteria
experienced no clinical disease. Results from this study could be used to
develop transmission models for different epidemiological scenarios. This
information could also be used to help improve disease management, particularly
in the context of selective breeding.
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1. INTRODUCTION
Salmonids, such as rainbow trout (Oncorhynchus mykiss), have been a
significant aquaculture species for centuries (Knapp et al. 2007, Chang et al.
2014) and, since the 1950s, there has been a rapid rise in rainbow trout
aquaculture (FAO, 2016). However, infectious diseases have had major impacts
on the growth of the trout industry. One such disease is bacterial cold water
disease (BCWD), also known as rainbow trout fry syndrome (RTFS) (Holt 1987,
Bruno 1992, Chua 1991). This disease is caused by a bacterial pathogen,
Flavobacterium psychrophilum, which is an opportunistic pathogen that is
associated with environmental conditions that increase host susceptibility, such
as low water quality and high fish densities (Decostere et al. 2000, Rottmann et
al. 1992). Flavobacterium psychrophilum is a gram negative, rod-shaped bacteria
that develops characteristic yellow colonies in culture media (Holt 1987,
Rangdale 1995, Madetoja 2000). The bacterium has been prevalent in the United
States since at least the 1940’s, (Davis 1946), but can now be found worldwide in
countries such as Australia, France, and Japan (Rangdale et al. 1997, Bernardet
et al. 1988, Amita et al. 2000), where it causes major losses to rainbow trout fry.
Juvenile trout are most susceptible to F. psychrophilum and suffer acute
systematic infections, often resulting in death. Adult fish show less severe
infections; however, the disease can still render them unsuitable for market.
Clinical signs include anemia, dark skin pigmentation, splenomegaly, and tissue
necrosis. However, the disease is most identifiable by a characteristic lesion that
forms near the caudal fin (Barnes et al. 2011). Additionally, the bacterium is
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highly diverse and new strains, with differing virulence levels, have been
described (Valdebenito & Herrera 2009). During outbreaks on farms, levels of
mortality up to 70% are regularly observed (Chua 1991, Lorenzen et al. 1991,
Starliper 2011) causing F. psychrophilum to be one of the leading pathogens in
rainbow trout aquaculture in the United States.
F. psychrophilum is transmitted horizontally when infected fish shed
bacteria into the water through urine and feces (Matejoda et al. 2000). There is
also evidence for intra-ovum vertical transmission, often making egg disinfection
ineffective (Brown et al. 1997). However, natural transmission over the course of
the infection is not well understood for this system, hindering disease
management. Waterborne transmission has proven difficult to simulate in the
laboratory, and typically infection studies rely on practices such as pathogen
injection, host skin abrasion, or mucus layer digestion to provide a portal of entry
(Madsen and Dalsgaard 1999; Madetoja et al. 2000, Jokumsen and Svendsen
2010). The quantity of pathogen shed into the environment is thought to be an
accurate and manageable proxy for transmission (Madetoja et al. 2000, Madetoja
et al. 2002, Wargo and Kurath 2012). However, how this transmission changes
depending on exposure dosage is not well characterized in this system. Studies
examining response to different pathogen dosages provide valuable insights into
evaluating host susceptibility and efficacy of strategies such as vaccination and
selection breeding (Langwig et al. 2017, and Gomes et al. 2014). Furthermore,
pathogen dosage in the field is highly variable (Ogut & Reno 2004, Murray 2009,
Salama & Murray 2011) and can heavily affect infectivity, virulence, and
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transmission (McKenney et al. 2016; van Gelderen et al. 2010, Cornick &
Helgerson, 2004).
In addition to variable pathogen dosage, host genetics are also highly
variable in the natural environment (Fjalestad et al. 1993). This results in
differences in disease susceptibility (VanderWaal & Ezenwa 2016) and pathogen
transmission within and between host populations (Lloyd-Smith et al. 2005, Paull
et al. 2012). There has been extensive research showing that rainbow trout
populations differ in their susceptibility to disease caused by F. psychrophilum
(Hadidi et al. 2008, Leeds et al. 2010). This variation has been shown to be
heritable, which has been capitalized on to create BCWD-resistant fish lines
through selective breeding (Wiens et al. 2013, Silverstein et al. 2009). However,
there is currently little understanding of how these host population differ in
pathogen transmission.
In this study, we sought to determine how exposure dosage and host
genetics influence the transmission of Flavobacterium psychrophilum. Bacterial
shedding kinetics over the 30-day course of infection were used as proxies for
transmission. These studies are directed towards improving disease
management in rainbow trout by informing F. psychrophilum transmission
dynamics under naturally variable field conditions.
2. MATERIALS AND METHODS
2.1 Fish lines
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Two genetic lines of rainbow trout (O. mykiss) were used in the experiments,
designated ARS-Fp-R, and ARS-Fp-S, to reflect genetic diversity that would be
found in aquaculture. Line ARS-Fp-R was bred exclusively for five generations to
be genetically resistant against mortality caused by F. psychrophilum strain CSF
259-93 (Wiens et al. 2013). Line ARS-Fp-S originated from the same ancestor as
line ARS-Fp-R, but was bred for one generation to be susceptible to BCWD, and
then randomly bred afterwards (Wiens et al. 2013). Selective breeding and
mortality resistance phenotyping has been conducted annually by the National
Cool and Cold Water Aquaculture (NCCCWA), United States Drug Administration
Agricultural Research Service Facility in West Virginia. Fish were weighed at the
beginning of the experiment and found to be 2 to 3 grams.
2.2 Bacterial propagation and enumeration
F. psychrophilum, strain CSF 117-10, was originally isolated in 2010 from a
clinical outbreak of BCWD in farmed rainbow trout at Clear Springs Foods, Idaho.
The isolate was cloned, sequenced, amplified, and frozen by collaborators at the
ARS NCCCWA facility in Kearneysville, WV (Hadidi et al. 2008). A single, frozen
vial was received by the Wargo lab at the Virginia Institute of Marine Science in
January 2014, at which point it was propagated on Tryptone yeast extract salts
(TYES) agar plates at 15°C for 4 days (Cain & LaFrentz 2007). A single colony
was then passaged to a second set of TYES agar plate at 15°C. After six days, a
single colony was selected and cultured in 15 ml of TYES media in a 250ml
Erlenmeyer flask, at 100 rpm orbital shaking, 15°C. After three days six ml of the
culture was combined with 50% glycerol in KPBS, mixed, divided in to one ml
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aliquots, and stored at -80°C. For the challenge experiments, a single vial of
glycerol stock was held on ice and streaked onto 150-mm TYES plates. Plates
were incubated at 15°C for seven days, after this , a single colony was selected
and put into 15mL of TYES media in a 125 mL Erlenmeyer flask. The top of the
flask was wrapped in parafilm, wrapped entirely in aluminum foil, and incubated
at 15°C on an orbital shaker at 150 rpm. After 24 hours, 250 uL of the small
culture was transferred into 100 mL of TYES media in a 250 mL Erlenmeyer
flask. The top of the flask was wrapped in parafilm, wrapped entirely in aluminum
foil, and incubated at 15°C with orbital shaking at 150 rpm, for 72 hours. After 72
hours, dilutions of the large culture were made using TYES media to create the
exposure dosages based on cell concentration. Bacterial inocula for the
experiment were measured by optical density (OD) at 525 nm, as 0.125OD, 0.25
OD, 0.50 OD, and 0.97 OD correlating to 6.4 x 103, 1.79 x 104, 7.35 x 105, and
3.75 x 106 CFU/mL, respectively. Bacterial cell number of the inoculum was
determined by direct plate counting, after the start of the experiment. To do so,
each inoculum dosage was plated in triplicate on TYES agar plates using an 8step, 10-fold serial dilution so as to produce countable plates with 20-100
colonies. This provided inoculum concentration in colony forming units injected
per fish.
2.3 Shedding experiment
Fish from each line (ARS-Fp-R, ARS-Fp-S) were anesthetized in 100 mg/L
tricaine methanesulfonate (MS-222) buffered with 300 mg/L sodium bicarbonate.
Once anesthetized, fish were then challenged with an intraperitoneal (i.p.)
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inoculum of F. psychrophilum in 50 µL of TYES media, using single doses of 0,
6.4 x 103, 1.79 x 104, 7.35 x 105, and 3.75 x 106 CFU/mL using a 27G ½” needle.
The fish were directly placed in approximately 3 L of water under aeration until
recovery, transferred to new 6 L tanks, and then washed at a flow rate of 15001600 mL/min for one hour to remove exposure bacteria. After washing, fish were
placed individually into randomly assigned 0.8 L tanks in a tower rack system
(Aquatic Ecosystems), with flow set to 150 ml/min. Once all fish were distributed
(approximately one hour), water flow was turned off, and a 1 ml water sample
was taken from each tank (Day 0). The tanks were then held static for 22 hours,
after which time 1 ml water was again sampled from each tank (Day 1). Holding
the water static allowed for accumulation and quantification of the total bacteria
shed over the previous 22-hour period. Water flow was turned on to 150 mL/min
for a two-hour wash to ensure all bacteria were removed from the tank (data not
shown) and then turned off again. This was repeated for Days 0-7. After
sampling on Day 7, tanks were flushed for 2 hours and then water flow set to 80
mL/min. On Day 9, 14, 19, and 24, tanks were flushed at 150 mL/min for 2 hours,
water was turned off for 22 hours, and then all tanks were sampled. Water
samples were stored at -80ºC until processed. Water temperature was
maintained at 15ºC ± 1°C throughout the experiment. Fish were taken off feed
24 hours prior to the experiment and then fed on Monday, Wednesday, and
Friday from day 1 forward. Over the 30-day course of the experiment, 28 fish
died; however, dead fish were kept in their tanks and their water continued to be
sampled as described above. At the end of the experiment, all of the remaining
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fish were euthanized with an overdose of 0.27 mg/ml MS-222 buffered with 0.09
mg/ml sodium. All fish experiments were approved by the William and Mary
IACUC under protocol number IACUC-2014-06-17-9666-arwargo.
2.4 Sample Processing
DNA was extracted from a 210 µL water sample using the AutoGenprep 965CE
DNA Extraction Kit. Aliquots of 10 ml of TDM1 were transferred to a 15 ml conical
vial and 600 µl of proteinase K was added. This mixture was lightly shaken and
finger vortexed. Using a repeater pipet, 50µl of TDM1/proteinase K mixture were
added to each well of a 96-well plate. Then 50 µl of TDM2 were added to each
well of the same 96-well plate. Samples were thawed, vortexed and 210 µl of the
sample was transferred to its designated well on the 96-well plate using a
multichannel pipettor. The plate was covered with sealing foil and placed in the
96-well assay block on an incubated plate shaker for 1 hour at 45°C at 1200
rotations per minute (rpms). The plate was then removed and centrifuged at 3000
rpm for 1 minute to remove any moisture from film. The AutoGenprep 965CE
protocol was then started at reagent 3 and finished according to kit instructions.
After the machine finished, the -96-well assay block was incubated on incubated
plate shaker at 37°C and 800 rpm for 2 hours. Samples were stored at 4°C for no
longer than 7 days prior to running qPCR. For quantification of DNA, samples
and controls were processed using FpSig probe and FpSigfwd and FpSig
primers (Marancik & Wiens 2012), TaqMan Universal Master Mix II + UNG
(Applied Biosystems) and a standard curve of purified CSF 259-93 bacterial
genomic DNA was used to convert cycle quantification (Cq) into log10 GE 100 ng85
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of input sample DNA (Marancik & Wiens, 2012) in qPCR. The qPCR detected

number of bacteria DNA copies in water samples presented as log10 (bacterial
copies per mL of water).
2.5 Statistics
Statistical analyses were carried out in R, version 3.2.2 (R Core Team 2015) and
RStudio (RStudio Team 2015). For all analyses, assumptions of homogeneity of
variance and normality were tested with residual plots, Levene’s tests, and
Shapiro-Wilk tests, where appropriate. Minimal models were chosen by
comparing model fits using AIC values, with differences greater than 2
considered significant. Under the assumption of parsimony, the simplest model
that converged, with equal or lower AIC was chosen. Of the 2200 samples that
were processed, only 2 samples tested positive out of the 440 negative controls
(fish not exposed to bacteria) which indicates a false positive rate of 0.45%.
2.5.1 Survivorship
Survival was visualized using Kaplan Meier Analysis with the survfit function in
the Survival package in R. Analyses were done using Cox proportional hazard
models in R with the coxph function in the Survival package (Therneau 2015).
Explanatory fixed factors in each of the models were fish line (categorical) and
dosage (continuous). Their interactions were also included. The baseline was
set to the ARS-Fp-R fish treatment.
2.5.2 Number of fish shedding bacteria
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Number of fish shedding was analyzed with a logistic regression. The response
variable in the model was the proportion of fish shedding per day (cbind (number
positive, number negative)) as indicated by a positive water sample. Day 0 and
the negative control dosage were not included in the model because our goal
was to determine if shedding differed between treatments from the point
shedding began, forward. Explanatory fixed factors in each of the models were
fish line (categorical), log10 dosage (continuous), and day (continuous), with
interactions included. A unique identifier for each fish (Fish ID, categorical)
nested in day was included in the model as a random factor, because the same
fish were sampled at multiple time points (repeated measures). Data was
analyzed using the glmer function in lme4 package (Bates et al. 2015) in R. The
baseline model was represented by the ARS-Fp-R fish treatment.
2.5.3 Mean intensity of bacterial shedding
Daily quantity of bacteria shed was analyzed with mixed effects models in R
using the lme function in the nlme packages (Pinheiro et al. 2015). The response
variable in the model was log10 (DNA copies of F. psychrophilum per mL +1).
Explanatory fixed factors were fish line (categorical), log10 dosage (continuous),
and day (continuous). Fish ID (categorical) nested in day was included in the
model as a random factor, because each fish was sampled at multiple time
points (repeated measures). Maximum likelihood estimation of parameters was
used due to its ability to allow for model selection and handle samples size of
less than 30 per treatment. Water samples with no detectable bacteria were
dropped from the analysis because our goal was to determine if the amount of
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shedding differed between treatments for fish that were actively shedding
bacteria. Thus, this analysis compares the mean density (intensity) of shedding
per day between positive fish only during the peak shedding period. The baseline
model was represented by the ARS-Fp-R fish treatment.
2.5.4 Total bacteria shed by individual fish
Total bacteria shed was analyzed using a negative binomial regression with the
glm.nb() function in the MASS package in R (Venabeles & Ripley 2002). The
response variable was the estimated number of bacteria shed by each individual
fish per day totaled over all days of the experiment and then log10+1
transformed. Explanatory fixed factors were fish line (categorical) and dosage
(continuous). Their interactions were also included. The negative control
treatment was dropped from the analysis, because we were interested in
comparing fish line and dosages impacts on shedding between fish exposed to
bacteria. However, fish exposed to bacteria that did not shed were included. The
baseline model was represented by the ARS-Fp-R fish treatment.
3. RESULTS
3.1 Survivorship
Mortality began on Day 3, peaked from Days 4-12, and then tapered off by Day
25 (figure 1). In general, the level of mortality was low. The bulk of mortality
occurred in fish exposed to the highest dosage of bacteria (3.75 x 10 6 CFU/mL)
in the ARS-Fp-R fish line. There was also significant mortality (50%) in the ARSFp-S line at the highest bacteria dosage. The mortality curves between the two
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fish lines varied slightly. Fish from the ARS-Fp-S fish died in two waves which
occurred between Day 3-12 and 20-24, while mortality for ARS-Fp-R was more
prolonged. There was very low mortality (5%) in ARS-Fp-R fish exposed to 7.35
x 105 CFU/mL, while no mortality occurred in any other treatment. When
comparing fish survivorship using a cox proportional hazard analysis, the model
that best fit the data included main effects of dosage and fish line. The model
revealed that the hazard of dying was 66% lower for ARS-Fp-S fish compared to
ARS-Fp-R fish (Supplemental table 1, p-value<0.01). The model also indicated
that for every unit increase in dosage, the hazard of dying increased by 32% (pvalue<0.001).
3.2 Number of fish shedding bacteria
In general, the number of fish shedding bacteria peaked around Day 3 and then
tapered off, such that the majority of fish were done shedding by Day 15 (figure
2). The logistic regression model that best fit the number of fish shedding data
included main effects of fish line, log10 dosage, and day, an interaction between
log10 dosage and fish line, as well as with a random term of fish ID nested in day.
The analysis revealed that there was a significant increase in shedding with
increasing dosage (figure 3, Supplemental table 2, p-value<0.001). There was
no significant difference in the likelihood of shedding between fish lines across
dosages (figure 3), time, or overall, despite suggestive trends that more ARS-FpR fish shed in some cases (p-value > 0.05). There was a significant decrease in
the probability of shedding through time (p-value<0.001), the rate of which was
similar across dosages (Supplemental figure 1). This meant that the probability of
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shedding was greater for higher bacteria dosages, both at the beginning and end
of the experiment.
3.3 Mean intensity of bacteria shedding
The intensity of bacterial shedding per day was variable through time and
depended on exposure dosage and fish line (figure 4). For fish that actively shed
bacteria, peak shedding typically occurred around Day 3, and then the intensity
of shedding decreased. The model that best fit the mean shedding intensity data
included day, log10 dosage, fish line, the log10 dosage by fish line interaction, and
the random term with fish ID nested in day. The model revealed that at the lowest
dosage, the intensity of shedding was less in the ARS-Fp-R compared to the
ARS-Fp-S fish line, while at the highest dosages it was less in the ARS-Fp-S line
(Supplemental table 3, p-value < 0.05). This indicated that, although shedding
intensity increased with dosage for both fish lines, it did so faster for the ARS-FpR line (figure 5). Shedding intensity also decreased slightly through time, but at
the same rate across all dosages and fish lines (p-value < 0.01).
3.4 Total bacteria shed
In an effort to compare bacterial fitness between treatments, the total amount of
bacteria shed by each fish was analyzed. A negative binomial model including
the main effects of fixed factors dosage and fish line best fit the data (figure 6).
As pathogen dosage increased, there was an increase in the total amount of
bacteria shed by both fish lines (Supplemental table 4, p-value < 0.001). This
increase was exponential, such that at the highest dosage shedding was six
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orders of magnitude higher than the lowest. There was no significant difference
between the fish lines in the amount that was shed (p-value=0.843).
4. DISCUSSION
In this study, we investigated bacterial shedding kinetics between two
different fish lines exposed to increasing dosages of Flavobacterium
psychrophilum. Little is known about shedding kinetics in this system (Madetoja
et al. 2000); however, other systems have shown that shedding is influenced by
pathogen strain (Cho et al. 2006) and host susceptibility (Woolhouse et al. 1997).
Our results indicated that even though mortality was low, a large number of fish
still shed bacteria. Exposure dosage had the greatest effect on shedding kinetics
when compared to fish line. Below we discuss some of the possible mechanisms
driving these observed patterns.
In this study, mortality was very low, and significant mortality only occurred
at the highest dosage. Studies conducted by Holt (1987) and Madetoja et al.
(2000) found similar low mortalities using the intraperitoneally-injected method
described here. The authors postulated that rainbow trout have immune
defenses in the peritoneal cavity that allow them to neutralize injected F.
psychrophilum cells and prevent colonization. Intramuscular injection causes
higher mortality than intraperitoneal injection in fish given the same dosage of F.
psychrophilum (Garcia et al. 2000), whereas immersion causes no mortality
(Madetoja et al. 2000). In the field, a portal of entry is thought to occur via
abrasion (Madetoja et al. 2000), and abrasion has been successfully used in the
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lab to produce infection in immersion exposures of trout with F. psychrophilum
(Garcia et al. 2000).
Our results indicated a significant difference between the two fish lines
such that the ARS-Fp-S line had a higher probability of survival compared to the
ARS-Fp-R line. This was the opposite of what we had found previously in our
studies, where the R line was more resistant (data not shown). One explanation
is that although the ARS-Fp-R line was successfully bred to be resistant to F.
psychrophilum CSF 259-93, in this study when challenged with a heterologous
strain, the resistance mechanism failed to prevent mortality. F. psychrophilum
strains are known to differ in virulence which is likely related to variation in the
lipopolysaccharide gene in the Flavobacterium genus (Zhang et al. 2006).
Resistance to one strain may confer resistance another. In addition, previous
studies had held larger numbers of fish in batches in exposures. In this study,
fewer fish were used and fish were separated into individual tanks to reduce
independence artifacts from group exposure and survival effects. Because there
is high genetic diversity within the fish lines, the overall effect of the ARS-Fp-R
line may be masked by genetic variation in the smaller sample size necessary for
this experiment.
Despite differences in survival at the highest dosage, there were no major
differences in shedding of the bacterium between the two fish lines. Selective
breeding, in this case, seems to induce a tolerance mechanism as opposed to
resistance mechanism for the ARS-Fp-S line. There was some indication that
shedding by the ARS-Fp-S line might increase more slowly with increasing
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dosage compared to the ARS-Fp-R line, however, perhaps suggesting a small
resistance mechanism in addition to tolerance. However, this was a very small
effect, and ultimately both fish lines shed the same amount over the entire
experiment.
Pathogen dosage had a large effect on survival and shedding in this
study. The effect was so strong that the overall potential of bacterial
transmission and fitness was six orders of magnitude higher at the highest
exposure dosage compared to the lowest, which far exceeded the difference in
dosage (three orders of magnitude). This suggests that quorum sensing or
density response is occurring (Zwart et al. 2011; Regoes et al. 2003), where an
increase in the number of bacteria in the host facilitates their proliferation, thus
leading to exponentially greater disease and transmission. This created a
threshold phenomenon that must be overcome in order to achieve mortality and
bacterial shedding. In this study, the bulk of fish mortality and bacterial shedding
occurred only at the highest exposure dosage, suggesting that a high exposure
dosage is required to pass the threshold in this system. Dosage did not impact
pathogen clearance rates, perhaps indicating that immune suppression was not
at play. As fish in aquaculture systems are exposed to different pathogen
dosages, they may not be effectively clearing the pathogen which may explain
why F. psychrophilum can consistently be found in farms (Matejoda et al. 2000,
Matejoda et al. 2002). Regardless of the mechanisms, these results highlight the
importance of considering pathogen exposure dosage in survival, transmission,
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or epidemiological modeling studies (Rogeos et al. 2003, Schmid-Hempel 2011,
Gomes et al. 2014, Langwig et al. 2017).
In summary, our results indicate that genetic differences between fish
lines influencing susceptibility to Bacterial Cold Water Disease may be weakly
correlated with F. psychrophilum transmission. This suggests that selective
breeding strategies solely targeting reductions in clinical disease may have
reduced efficacy for long-term pathogen control in rainbow trout. Pathogen
exposure dosage, route of infection, and strain are also likely to heavily impact
efficacy of selective breeding and other management strategies. Future studies
examining the generalizability of resistance across conditions reflecting natural
field variability are likely to improve disease management programs and provide
insights into the mechanisms of susceptibility. Collectively, these results could
be used to develop transmission models and other tools for epidemiological
inference in trout aquaculture. Incorporating variation in host susceptibility into
these models is likely to be an important consideration and could provide
valuable insights for selective breeding.
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Figures

Figure 1. Kaplan-Meier survival analysis for trout exposed to Flavobacterium
psychrophilum. Lines represent survivorship through time of ARS-Fp-S fish
(dotted line) or ARS-Fp-R fish (solid line) exposed to different dosages (CFU/mL)
of bacteria (denoted by color). Lines that are not visible had zero mortality
(survival =1) and overlap.
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Figure 2. Number of fish shedding Flavobacterium psychrophilum per day across
all fish lines. Lines represent total number of fish out of 20 that had detectable
IHNV shedding by qPCR, through time. ARS-Fp-S fish are represented by the
dotted line, and ARS-Fp-R fish are represented by the solid line. The color in the
legend represents the challenge dosage of bacteria in CFU/mL. Lines that are
not visible had zero fish shedding.
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Figure 3. Association between likelihood of fish shedding and exposure dosage.
Lines represent best fit linear trend of predicted likelihood of bacteria shedding
across log10(bacteria exposure CFU/ml) from statistical models (described in
methods), for the ARS-Fp-S (gray) and ARS-Fp-R fish lines (black). The gray
shading is the 95% confidence interval around the model fit line.
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Figure 4. Intensity of bacteria shed over time. Each panel shows the
log10(bacteria DNA copies shed/ml H2O), through time, across various bacterial
challenge dosages (CFU/ml, signified by color). Only fish that shed bacteria,
dead or alive, were included. If not point is shown, all fish were negative. ARSFp-S fish are represented by the dotted line, and ARS-Fp-R fish are represented
by the solid line.
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Figure 5. Predicted association between bacteria shed and exposure dosage.
Lines show predicted linear association between log10 (shed bacteria DNA
copies/ml of H20) and log10 (exposure bacteria CFU/ml), from statistical model
(see methods). Values for ARS-Fp-S ARS-Fp-R are shown in grey and black
respectively. The gray shaded region around the lines represents the 95%
confidence interval. Points represent predicted values for each fish, some of
which overlap.
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Figure 6. Total bacteria shed over the course of the infection. Bars represent the
mean of the log10 (total bacteria DNA copies/mL water +1) of each fish ±
standard deviation (error bars), at different challenge dosages (CFU/ml). ARSFp-S and ARS-Fp-R are shown in grey and black respectively. If there is no bar,
no fish in that treatment shed bacteria over the course of the infection.
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Supplement

1. Survivorship
Model: coxph(Surv(Day.Dead, Dead) ~Fish.Line+Dosage, data=bac.mort.data)
Wald test= 21.86 on 2 degrees of freedom, p=1.792-05, n= 200, number of event
s= 28
Table 1. Model output for Survivorship.
coef exp(coef) se(coef)
z
Pr(>|z|)
Fish.LineARS-Fp-S
-1.0858
0.3376
0.4042 -2.686
0.00722 **
Dosage
3.9949
54.3195
1.0043 3.978 6.95e-05 ***
--Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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2. Number of fish shedding bacteria
Model: glmer(cbind(Number.for.positive.count,Number.for.neg.count)~ Fish.Line
+Dosage+Day+ Dosage*Day + (Day|Tank.Number), family=binomial, data=prop.
suc.fail.df3)
Generalized linear mixed model fit by maximum likelihood (Laplace Approximatio
n) ['glmerMod']
AIC
796.7

BIC
839.7

logLik
-390.3

Table 2. Model output for Number of fish shedding.
Estimate
Std. Error
(Intercept)
-9.94067
1.06558
Fish.Line ARS-Fp-S
-0.55306
0.43982
Dosage
3.43882
0.35489
Day
0.07192
0.10886
Dosage:Day
-0.10408
0.03213
--Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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deviance
780.7

z value
-9.329
-1.257
9.690
0.661
-3.240

df.resid
1592

Pr(>|z|)
<2e-16 ***
0.2086
<2e-16 ***
0.5088
0.0012 **

Supplemental Figure 1. Predicted likelihood of fish shedding. Lines represent
best fit linear trend of predicted daily likelihood of bacterial shedding, from
statistical models (described in methods). The gray shading is the 95%
confidence interval around the model fit line. The dots are fitted values for
individual fish. Some fish have the same predicted value and dots overlap.
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3. Mean intensity of bacteria shedding
Model: lme(Log.Quantity~Day+Dosage+Fish.Line+Dosage:Fish.Line, random=~
Day|Tank.Number, data=quant.data, + method="ML", na.action="na.omit", weight
s=varExp(), correlation=corAR1())
Table 3. Model output for Mean intensity of bacteria shedding.

(Intercept)
Day
Dosage
Fish.LineARS-Fp-S
Dosage:Fish.LineARS-Fp-S

Value
1.9911
-0.0480
0.7376
1.0328
-0.3992

Number of Observations: 370
Number of Groups: 83
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Std.Error DF
t-value
0.4406 286 4.51856
0.0182 286 -2.62498
0.1200
79 6.14410
0.6277
79 1.64548
0.1713
79 -2.32934

p-value
0.0000
0.0091
0.0000
0.1038
0.0224

4. Total bacteria shed
Model: glm.nb(Quantity~Fish.Line+Dosage, data=tot.shed, link=log)
Table 4. Model output for Total bacteria shed.

(Intercept)
Fish.Line ARS-Fp-S
Dosage
---

Estimate
-1.25180
-0.03624
0.73553

Std. Error
0.24490
0.14960
0.07377

z value
-5.112
-0.242
9.971

Pr(>|z|)
3.2e-07 ***
0.809
< 2e-16 ***

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial (2.7525) family taken to be 1)
Null deviance: 350.92 on 159 degrees of freedom
Residual deviance: 228.60 on 157 degrees of freedom
Number of Fisher Scoring iterations: 1
Theta: 2.75
Std. Err.: 1.65
2 x log-likelihood: -594.185
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ABSTRACT
Infections with multiple pathogen species, known as co-infections, are common
in nature. How co-infection impacts disease dynamics has received increased
attention, yet the impact on transmission remains largely unknown. In an attempt
to fill these gaps for an important fish host, we evaluated how co-infection
between two major rainbow trout (Oncorhynchus mykiss) pathogens, infectious
hematopoietic necrosis virus and Flavobacterium psychrophilum, impacted
clinical disease and pathogen shedding. We observed a facilitation effect,
wherein host mortality and transmission potential were higher in co-infection
compared to single infections. The effect was more pronounced for the bacterium
than the virus and depended on fish genetics, such that fish genetics had an
impact during single infection, but were quickly overwhelmed in co-infection. Our
results demonstrate the importance of considering co-infection for disease
management, particularly for the two pathogens studied here.
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1. INTRODUCTION
Co-infections are ubiquitous in nature (Griffiths et al. 2014, Kotob et al. 2017)
and are defined by two or more pathogen species infecting a host at the same
time. Studies of co-infection have increased in recent years (Viney and Graham
2013, Buhnerkempe et al. 2015); however, the majority of this work has focused
on disease or within-host dynamics (Alonso et al. 1999, Byrne et al., 2008, Long
et al., 2010, Lorenzen et al., 2002, Wargo et al. 2010). Although these studies
have shown that co-infections affect disease dynamics, ecology, and evolution
(Kotob et al. 2017, Susi et al. 2015), very few look at the effects on transmission
(Ezenwa and Jolles 2011). This is surprising, given that transmission is an
important determinant of pathogen fitness (Wargo and Kurath 2012).
In general, there are three outcomes for the impact of co-infection on
transmission of pathogens compared to single infections (Read and Taylor
2001). (1) Competitive suppression is when pathogens compete for resources
within the host, potentially through the immune system, where one or both may
suffer in terms of replication and transmission. (2) Neutral interaction is also
possible where the individual pathogens do not affect each other and within host
dynamics as well as transmission do not change. (3) Lastly, facilitation may occur
where one or both pathogens benefit from each other such that within host
replication and transmission increase (Vaumourin et al. 2015). Minor variants or
combinations of these scenarios are also possible. Each of these outcomes has
important ecological and evolutionary implications, which ultimately influence
disease management decisions. For example, competitive suppression is
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believed to select for the evolution of increased virulence (Read and Taylor 2001,
Bell et al. 2006, May and Nowak, 1995); whereas facilitation, on the other hand,
may result in higher levels of clinical disease than predicted based on the density
of the pathogens separately (Read and Taylor 2001).
Although the theoretical literature of how co-infection impacts transmission is
vast (Graham et al. 2007, Susi et al. 2015), laboratory studies are limited; but
there are a few notable exceptions. Cho et al. (2006) studied transmission of
Procine Reproductive and Respiratory Syndrome Virus (PRRSV) in co-infection
with Mycoplasma hyopneumoniae in pigs and found that when infected with both
pathogens, the pigs had a higher probability of shedding PRRSV, suggesting a
facilitation mechanism. While these studies provide valuable insight, more
research is needed to develop a generalizable understanding. This is particularly
true in aquatic pathogen systems, where routes of transmission are likely to be
different from terrestrial ones (McCallum et al. 2004).
We investigated the impact of co-infection on the transmission of two major
salmonid fish pathogens, infectious hematopoietic necrosis virus (IHNV) and
Flavobacterium psychrophilum. IHNV is a single-stranded, negative-sense RNA
virus in the Rhabdoviradae family (Bootland and Leong 1999) that infects various
salmonid species, and is particularly problematic in rainbow trout (Oncorhynchus
mykiss) aquaculture. The virus is believed to have originated in the Pacific coast
of North America, but has spread worldwide (Rodger 2016). The virus is
transmitted when the fish shed the pathogen into the water (Suttle 2007, Traxler
et al. 1993). It causes an acute disease (Troyer et al. 2000), with epidemics in
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trout farms and hatcheries often reaching up to 100% mortality (Bootland and
Leong 1999), resulting in extreme economic loss (Kotob et al. 2017).
Flavobacterium psychrophilum is another major pathogen in rainbow trout
aquaculture. This gram-negative bacterium is the causative agent of rainbow
trout fry syndrome (RTFS) and bacterial cold-water disease (BCWD) (Lafrentz
and Cain 2004). Like IHNV, the bacteria was thought to have originated in and be
limited to North America (Anderson and Conroy 1969), but it can now be found
globally (Amita et al. 2000; Bernardet et al. 1988; Rangdale et al. 1997).
Transmission of F. psychrophilum occurs horizontally when fish shed the
pathogen into the water, or vertically through an intra-ovum pathway
(Nematollahi et al., 2003). This has made management of transmission through
strategies such as egg disinfection challenging. The pathogen causes an acute
disease resulting in clinical signs such as lethargy, tissue necrosis, and
inflammation, and high mortalities up to 90% (Nilsen et al. 2011), depending on
environmental conditions.
Co-infections between IHNV and F. psychrophilum are believed to commonly
occur in nature (LaFrentz et al. 2004). Although not extensively studied, the
ecology of these two pathogens differs. F. pschyrophilum is believed to be an
opportunistic pathogen, with fish on farms harboring infections continuously, but
clinical disease only occurring under certain environmental conditions (Neiger
and Barnes 2012). In contrast, IHNV is thought to exhibit a more epidemic
pattern, with pathogen and disease outbreaks occurring sporadically (St-Hilaire
et al. 2002). There is strong anecdotal evidence from the field that co-infections

118

between the pathogens in fish farms in Idaho (LaFrentz et al. 2004). To our
knowledge, Ma et al. (2019) found that fish co-exposed to low doses of IHNV and
F. psychrophilum had increased levels of clinical disease. Their results indicated
this was a result of increased pathogen loads compared to single infections,
again suggesting pathogen facilitation. However, the study did not investigate the
impact of co-infection on transmission. Furthermore, the fish in this study were
held in batch conditions, where multiple rounds of pathogen transmission
between hosts could occur, so exposure dosage may have been variable. Some
work has also been done examining IHNV and F. psychrophilum in co-infection
with other pathogens. For example, a study of IHNV in co-infection with infectious
pancreatic necrosis virus (IPNV) found disease and the proportion of times IHNV
completed the replication and transmission cycle decreased, while IPNV
remained unaffected suggesting that IPNV interfered with IHNV replication
(Alonso et al. 1999, Byrne et al. 2008); however, transmission of the pathogens
was not assessed. Transmission of IHNV is affected by multiple strains of the
virus in the same host, which indicates competitive suppression among strains
(Wargo and Kurath 2012, Wargo et al. 2017, Kell et al. 2013, Breyta et al. 2016);
however, co-infection between different species was not investigated.
How co-infection dynamics are shaped by host genetics has not been well
studied (Chambuso et al. 2018). This is particularly relevant for IHNV and F.
psychrophilum because trout populations have been found to vary in their
susceptibility to each pathogen (LaPatra 1998, Purcell et al. 2010, Hadidi et al.
2008, Wiens et al. 2013), potentially leading to differences in co-infection
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dynamics. Fish that have acquired resistance to one pathogen may have a
different co-infection dynamic compared to hosts that are more susceptible.
In this study, we quantified the impact of co-infection on disease and
pathogen transmission of IHNV and Flavobacterium psychrophilum in rainbow
trout. To achieve this goal, we exposed genetically divergent fish lines to single
and co-infections of IHNV and F. psychrophilum and quantified mortality and
shedding kinetics of each pathogen from individual fish. Studies have shown that
shedding correlates to transmission (Madetoja et al. 2000, Doumayrou et al.
2019); therefore shedding was used as a proxy for transmission. This work is
aimed at improving transmission models for management of these pathogens in
the field, where co-infection commonly occurs. Traditionally management has
focused on single infections of these two pathogens, however dynamics may be
very different in co-infection, potentially leading to spurious inferences.
2. MATERIALS AND METHODS
2.1 Fish lines
Two rainbow trout fish lines were used in the experiments, designated
ARS-Fp-R and ARS-Fp-S, to reflect genetic diversity that would be found in
aquaculture. Line ARS-Fp-R was bred exclusively for five generations to be
genetically resistant to disease caused by F. psychrophilum strain CSF 259-93
by the National Center for Cool and Cold Water Aquaculture (NCCCWA), USDA
ARS Facility in West Virginia. Line ARS-Fp-S originated from the same ancestor
as line ARS-Fp-R, but was bred for one generation to be susceptible to disease
caused by F. psychrophilum strain CSF 259-93, and then randomly bred for four
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generations by the NCCCWA (Wiens et al. 2013). Fish weighed 2.5 to 3.0 grams
on average at the start of the experiment.
2.2 Pathogens
The viral pathogen used for the experiments was infectious hematopoietic
necrosis virus (IHNV, species: Salmonid novirhabdovirus) genotype C (genbank
accession number: AF237984). This genotype is part of the M genogroup and
was first isolated in the Idaho trout aquaculture region (Kurath et al. 2003). For
these studies, a new virus stock was propagated and titered on Epithelioma
Papulosum Cyprini (EPC) cells following protocols in Jones et al. (submitted).
The bacterial pathogen used was F. psychrophilum, strain CSF 117-10, originally
isolated in 2010 in the same Idaho trout aquaculture region as the IHNV isolate,
during a clinical outbreak of BCWD. The isolate was cloned, amplified, and
frozen by collaborators at the ARS NCCCWA facility in Kearneysville, WV (Hadidi
et al. 2008). A clonal culture was propagated and enumerated using protocols in
Jones et al. (unpublished). In order to ensure that all fish exposed to both
pathogens became infected, high pathogen dosages were used in the
experiment.
2.3 Shedding Experiment
Fish from each line (ARS-Fp-R, ARS-Fp-S) were anesthetized in 100
mg/L tricaine methane sulfonate buffered with 300 mg/L sodium bicarbonate.
Once anesthetized, fish were challenged with an intraperitoneal (i.p.) inoculum of
50 µL of TYES buffer (mock bacteria exposure) or F. psychrophilum at 8.5 x 105
CFU/fish. They were then directly placed in a 2 L bucket with aeration and
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allowed to recover from anesthesia. After the entire group of twenty fish fully
recovered (were swimming normally), the fish were transferred to new 6 L tanks
and were exposed to MEM-10 buffer (mock virus exposure) or IHNV in MEM-10
buffer at 1 x 106 PFU/mL through immersion. Exposure to IHNV typically
occurred within 5 minutes of inoculation with F. psychrophilum. After one hour,
the fish were moved to a new 6 L tank where they were washed at a flow rate of
1500-1600mL/min for one hour to remove excess pathogens. The fish were then
placed individually into randomly assigned 0.8 L tanks in a tower rack system
(Aquatic Ecosystems), with flow rate set to 150 ml/min. After all fish were
distributed (approximately one hour), water flow was turned off, and a 1 ml water
sample was taken from each tank (Day 0). Water samples were then taken from
each tank on Days 0 to 7, 10, and 19, using protocols from Jones et al.
(unpublished). Water temperature was maintained at 15ºC ± 1°C throughout the
experiment. Fish were taken off feed 24 hours prior to the experiment and then
fed on Monday, Wednesday, and Friday from day 1 forward. Over the 30-day
course of the experiment, 81 fish died; however, dead fish were kept in their
tanks and their water continued to be sampled as described above. At the end of
the experiment, all of the remaining fish were euthanized with an overdose of
0.27 mg/ml tricaine methanesulfonate buffered with 0.09 mg/ml sodium. All fish
experiments were approved by the William and Mary IACUC under protocol
number IACUC-2014-06-17-9666-arwargo.
2.4 Sample Processing
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DNA and RNA were extracted from 210 µL water samples using the cador
Pathogen 96 Qiacube HT Kit (Qiagen) with a Tecan Freedom Evo 100 liquid
handling robot, as per manufacturer guidelines with modifications in Jones et al.
(submitted). Following extraction, 15 µL was transferred to a 96-well plate, frozen
at -80°C, and sent to NCCCWA to be processed for bacterial shedding
quantification, using qPCR on DNA as previously described (Jones et al. in prep).
Viral shedding was quantified using RT-qPCR on RNA as previously described
(Jones et al. submitted).
2.5 Statistics
Statistical analyses were carried out in R, version 3.2.2 (R Core Team 2015) and
RStudio (RStudio Team 2015). For all analyses, assumptions of homogeneity of
variance and normality were tested with residual plots, Levene’s tests, and
Shapiro-Wilk tests. Minimal models were chosen by comparing model fits using
AIC values, with differences greater than 2 considered significant. Under the
assumption of parsimony, the simplest model that converged, with equal or lower
AIC was chosen. The best fit model for each analysis can be found in the
supplemental material. For ease of readership, we summarize the model
inferences in the main body text. The bacteria and virus shedding data were
analyzed separately. Each dataset contained treatments of either pathogen in
single infection, referred to as “IHNV alone” or “FP alone”, or in co-infection; in
each fish line. Inferences about differences between factor levels were made
using predicted mean values from models, obtained with the predict() function.
Where 95% confidence intervals did not overlap means were considered
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significantly different. Of the 1600 viral samples that were processed, only 3
samples tested positive out of the 800 negative controls (fish not exposed to
virus) which indicates a false positive rate of 0.375%. Of the 1600 bacteria
samples that were processed, only 18 samples tested positive out of the 800
negative controls (fish not exposed to bacteria) which indicates a false positive
rate of 2.25%. Due to false positives, a mean quantity of the false positives for
bacteria and virus data was subtracted from all of the other values in the
respective data sets and models were re-run using the corrected values, which
are shown here. After this correction, negative controls were excluded from all
figures and analyses.
2.5.1 Survivorship
Survival was visualized using Kaplan Meier analysis with the survfit function in
the Survival package in R. Analyses were done using Cox proportional hazard
models in R with the coxph functions in the Survival package (Therneau 2015)
and the pairwise_survdiff function from the Survminer package (Kassambarra et
al 2017). Explanatory fixed factors in each of the models were fish line
(categorical) and treatment (categorical) which included IHNV alone, FP alone,
and co-infection. Their interactions were also included. The baseline was set to
the ARS-Fp-R fish line in co-infection.
2.5.2 Number of fish shedding each pathogen
The number of fish shedding bacteria or virus was analyzed with a logistic
regression. The response variable in the model was the proportion of fish
shedding each pathogen per day (cbind (number positive, number negative)) as
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indicated by a positive water sample. Day 0 and the negative control were not
included in the model because our goal was to determine if shedding differed
between treatments from the point shedding began, forward. Explanatory fixed
factors in each of the models were fish line, treatment (IHNV alone or FP alone,
and co-infection), and day. Their interactions were also included. A unique
identifier for each fish (fish ID) nested in day was included in the model as a
random factor, because the same fish were sampled at multiple time points
(repeated measures). Data were analyzed using the glmer function in lme4
package (Bates et al. 2015) in R. The baseline was set to the ARS-Fp-R fish line
in co-infection.
2.5.3 Pathogen shedding intensity through time
Daily quantity of virus or bacteria shed was analyzed with mixed effects models
in R with the lme function in the nlme packages (Pinheiro et al. 2015). The
response variable in the model was log transformed RNA/DNA copies of IHNV or
F. psychrophilum per mL. Explanatory fixed factors were fish line, treatment
(IHNV alone or FP alone, and co-infection), and day. Fish ID nested in day was
included in the model as a random factor, because each fish was sampled at
multiple time points (repeated measures). Maximum likelihood estimation of
parameters was used due to its ability to handle samples size of less than 30 per
treatment. Water samples with no detectable pathogen were dropped from the
analysis because our goal was to determine if the amount of shedding differed
between treatments for fish that were actively shedding a pathogen. Thus, this
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analysis compares the intensity of shedding between fish during the peak
shedding period. The baseline was set to the ARS-Fp-R fish line in co-infection.
2.5.4 Total amount of pathogen shed
Total bacteria or virus shed was analyzed using a negative binomial regression
with the glm.nb() function in the MASS package in R (Venabeles & Ripley 2002).
The response variable was the amount of pathogen shed by each individual fish
per day totaled over the experiment and then log +1 transformed. Explanatory
fixed factors were fish line and treatment (IHNV alone or FP alone and coinfection). Their interactions were also included. The baseline was set to the
ARS-Fp-R fish line in co-infection.

3. RESULTS
3.1 Survivorship
Mortality began around Day 4 and tapered off by Day 23, with the peak of
mortality between Days 4-12 (figure 1). Analysis of the mortality data revealed
that F. psychrophilum alone had a much higher proportion of survival compared
to IHNV alone (Supplemental Table 1, p-value<0.01). Overall, co-infection greatly
increased the hazard of dying, compared to single infections of FP alone, to an
equal degree in both fish lines. Co-infection also increased mortality compared to
IHNV alone (p-value<0.05), but only for the ARS-Fp-R line. As such, the ARS-FpR fish line had lower mortality than ARS-Fp-S line for IHNV alone (Supplemental
Table 2, p-value<0.01). There was no difference in mortality between fish lines
for the FP alone treatment.
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3.2 Number of fish shedding each pathogen
In general, shedding of IHNV began and peaked between Days 2 -3.
Shedding continued until Day 7 after which the number of fish shedding gradually
tapered (figure 2a). The exception was for the IHNV alone treatment, in which the
number of fish shedding tapered off faster. Logistic regression analysis revealed
that there was a significant decrease in probability of fish shedding IHNV over
time (Supplemental Table 3, p-value <0.001). The model also indicated that the
effect of co-infection was dependent on the fish line (Supplemental Table 3, pvalue<0.05), such that in the ARS-Fp-S line co-infection decreased the
probability of fish shedding IHNV whereas in the ARS-Fp-R line it increased it.
This resulted in a higher probability of IHNV shedding in single infection in the
ARS-Fp-S line but no difference in the probability of IHNV shedding between fish
lines in co-infection (Supplemental Figure 1).
Bacterial shedding kinetics were quite different from the virus, with the
number of fish shedding peaking on Day 2, remaining high for co-infections, and
rapidly tapering off in single infections (figure 2b). Logistic regression analysis
revealed that there was a significant decrease in number of fish shedding
bacteria over time (Supplemental Table 4, p-value <0.001). Additionally, coinfection increased the probability of shedding bacteria (p-value <0.001). There
was no difference in the probability of bacterial shedding between fish lines, for
either single or co-infections (Supplemental Table 4, P>0.05).
3.3 Mean intensity of each pathogen shedding in infected fish
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The mean intensity for viral shedding through time peaked at Day 2 and
remained high until a slight decrease around Day 6 (figure 3a). The analysis
revealed that the intensity of viral shedding significantly decreased through time
(Supplemental Table 5, p-value < 0.01), the rate of which did not differ between
single and co-infections, or fish lines (Figure 4). The effect of competition on viral
shedding intensity was dependent on fish line, as observed for the number of fish
shedding analysis. In the ARS-Fp-R fish line, coinfection increased IHNV
shedding intensity compared to single infections. However, coinfection had no
effect on shedding intensity in the ARS-Fp-S line (Figure 4). This also resulted in
IHNV shedding intensity being lower for the ARS-Fp-R line in single infections,
compared to the ARS-Fp-S line, but not in co-infections.
For the bacteria, shedding intensity peaked at Day 1 but did not
significantly decrease over time in either infection or fish line treatment (figure 3b,
Supplemental Table 6, p-value-0.5622). Overall, the intensity of bacterial
shedding was higher in co-infection compared to single infection (Supplemental
Table 6, p-value = 0.024). There was no difference in mean intensity for bacterial
shedding between fish lines (p-value = 0.8549).
3.4 Total amount of pathogen shed
In an effort to compare the effect of competition on absolute fitness for
both pathogens, the total amount of virus or bacteria shed by each fish was
analyzed (figure 5). The analysis indicated that there was no significant
difference in the total amount of virus shed between the single and co-infection
treatments, despite a trend that there was more shedding in co-infection for the
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ARS-Fp-R line (Supplemental Table 7, p-value>0.05). In contrast, significantly
more total bacteria were shed in co-infections compared to single infections
(Supplemental Table 8, p-value<0.01). There was no difference in total shedding
between fish lines for either pathogen (p-value>0.05).

4. DISCUSSION
Co-infections are ubiquitous in many host populations (Alonso et al, 1999,
Griffiths et al. 2014, Hawley and Altizer, 2011; Munson et al. 2008, Ramilo et al.
2013). How co-infection affects pathogen transmission has been hypothesized
(Susi et al. 2015) but rarely studied. Here, in co-infection between IHNV and
Flavobacterium psychrophilum, a potential facilitation effect was observed, in that
there was more mortality and greater shedding during co-infection compared to
single infections. This effect was most pronounced for the bacterium, but was
also observed in some parameters for the virus in one fish line. These findings
are consistent with observations from the field (LaFrentz et al. 2004) and
previous studies (Ma et al. 2019), which have shown that co-infection between
these pathogens leads to larger epidemics, more clinical disease, greater
histopathology, and higher within-host pathogen loads. Our study expanded
upon this work by demonstrating that co-infection leads to greater pathogen
shedding, which equates to higher transmission potential.
Our findings are similar to what has been observed during co-infection in
other systems (Graham 2008, Xu et al. 2009, Kotob et al. 2017, Graham et al.
2007), as the effect of facilitation was more pronounced for clinical disease than
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shedding. Here, co-infection increased disease in all cases but one, and the
effect was pronounced, such that almost all co-infected fish died within six days,
whereas the majority of single infection fish survived until at least Day 10.
Additionally, probability and intensity of shedding increased for both pathogens,
but total shedding only increased for the bacterial pathogen. As such, increases
in mortality were greater than increases in shedding. This suggest that increased
mortality is due to both increases in pathogen load and reductions in ability to
tolerate a given load. Similar results were seen by Ma et al. (2019) where
mortality and within-host pathogen loads increased in co-infection, but antibody
titer did not. Interestingly, a large amount of shedding occurred after fish died,
particularly in the co-infection treatments. This may indicate that transmission
occurs after host death, which is often assumed not to be the case when
modeling transmission of fish pathogens (Ögüt 2001). The infectivity of IHNV and
F. psychrophilum shed from dead fish warrants further investigation.
Co-infection had a greater effect on the bacterium than the virus. In
general, the virus was more virulent (Bootland and Leong 1999, Nematollahi et
al. 2003), so this difference could be attributed to a saturation effect. Previous
studies looking at different exposure dosages in single and co-infection have
shown that mortality significantly increases with increasing pathogen dosage until
a certain saturation point (Jones et al submitted, Langwig et al. 2017, Xu et al.
2009). A dose response study in co-infection may shed light on this finding,
especially if the co-infection dynamic is dose dependent. Our results do shed
some light on the immune mechanisms against F. psychrophilum and IHNV.
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Overturf and LaPatra (2006) found that IHNV generated a stronger and more
consistent immune response compared to F. psychrophilum, which caused
variable expression levels for several immune genes. If IHNV is more immune
stimulatory (Purcell et al. 2004), it may drive the hosts towards a type I response,
resulting in a decrease in the type II immune response (Henriksen et al. 2015).
Studies have shown F. psychrophilum is regulated by type II immunity, and
therefore a decrease in this response may allow for enhanced proliferation of the
bacteria, as observed here. In other words, the strong antiviral response may be
limiting the immune response to the bacteria.
Fish line had an important influence on the effect of competition more so
for the virus than the bacteria. The ARS-Fp-R line was less susceptible to the
virus, but this was diminished in co-infection. Furthermore, in the more
susceptible host (ARS-Fp-S line), there appeared to be a threshold in viral
shedding. It is unclear whether this was a result of genetic resistance or other
mechanism, given that ARS-Fp-R was bred for resistance against a specific
strain of F. psychrophilum. Given that the two pathogens have different
mechanisms for evading the host immune system (Wu et al. 2017, Nematoholli et
al. 2003), it is unlikely that resistance to one would provide resistance to the
other, but this warrants further investigation. Interestingly, we observed no
difference between fish lines in resistance to the bacterium, which is in contrast
to previous work by Weins et al. (2013). It is also important to note that mortality
from F. psychrophilum alone was low, likely due to different bacterial strains
being used between this study and Weins et al. (2013). Regardless, our results
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show increased mortality and transmission during co-infection indicating that
selective breeding regimes targeting a single pathogen may be overwhelmed in a
co-infection setting.
Interestingly, patterns in the probability and intensity of pathogen shedding
were not reflected in total amount of pathogen shed, especially for the virus. This
effect may be due to the total amount of pathogen shed being driven by the peak
where the majority of pathogen shedding occurred early in the infection where all
fish were shedding. Previous studies support this hypothesis where the majority
of shedding of IHNV occurred around the peak of shedding at Day 2 (Wargo et
al. 2017, Jones et al. submitted). This is also a function of the probability of
shedding changing more than the intensity. Total shedding appears to be driven
by one or two fish shedding two or more orders of magnitude more pathogen that
the rest. These “super-spreaders” are common in this and other systems
(Chase-Topping et al. 2008, Wargo and Kurath 2011, Wargo et al. 2017). This
highlights the importance of considering shedding kinetics through time rather
than absolute shedding, especially if transmission is restricted to certain time
points or fish are in low density situations and transmission event are rare
(Kilpatrick and Alitzer 2010).
This study illustrates the importance of considering co-infections when
determining transmission of pathogens and how they are impacted by
preventative measures, such as breeding for genetic disease resistance. Coinfection exacerbated mortality and transmission of both pathogens, indicating
facilitation. There was some indication that this facilitation effect might overwhelm
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management strategies, such as selective breeding. How it might impact other
strategies such as vaccination warrants investigation. Our results indicate that
removal of one pathogen from this system is likely to have added benefit of
reducing disease caused by the other. However, it also implies estimates of
management efficacy based on single infections will be underestimated in field
settings where co-infection is common. Investigations of other factors, such as
pathogen dosage and environmental conditions on the co-infection interaction,
warrant investigation. Co-infection scenarios are being studied more regularly,
however transmission dynamics are still understudied. These results should be
considered when designing transmission models given that co-infection appears
to change transmission dynamics.
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Figures

Figure 1. Survivorship of trout exposed to IHNV and Flavobacterium
psychrophilum in single and co-infection. Lines represent the Kaplan-Meier
survivorship through time of ARS-Fp-S (dotted line) or ARS-Fp-R fish (solid line)
exposed to the bacteria (blue), virus (orange), neither (pink), or both (green).
Lines that are not visible had zero mortality (proportion survival =1) and overlap.
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Figure 2. Number of fish shedding pathogen per day. Lines represent total
number of fish out of 20 that had detectable IHNV (panel a) or F. psychrophilum
(panel b) shedding by qPCR, through time. ARS-Fp-S fish are represented by
the dotted line, and ARS-Fp-R fish are represented by the solid line. The color in
the legend represents the exposure to each pathogen in single or co-infection.
Points represent when samples were taken. Lines that are not visible had zero
fish shedding.
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Figure 3. Mean intensity of pathogen shed per day. Lines represent mean log
quantity of detectable IHNV (panel a) or F. psychrophilum (panel b) shedding by
qPCR, through time. ARS-Fp-S fish are represented by the dotted line, and
ARS-Fp-R fish are represented by the solid line. The color in the legend
represents the exposure to each pathogen in single or co-infection. Points
represent when samples were taken. Of the 20 fish per treatment, only positive
fish were included in this graph. Lines that are not visible had zero fish shedding.
145

Figure 4. Predicted mean IHNV shedding intensity over time. The lines represent
the predicted viral load [log10(viral RNA copies/mL H2O)] shed by each fish line
over time when exposed to IHNV alone (gray) and both pathogens in co-infection
(black). Values come from statistical model (Supplemental Table 4)
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Figure 5. Total amount of pathogen shed over the course of the experiment. Bars
represent log total quantity of IHNV (panel a) or F. psychrophilum (panel b) shed
by ARS-Fp-S fish (gray) and ARS-Fp-R fish (black) when exposed to each
pathogen in single and co-infection. Error bars represent standard deviation
around the mean.
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Supplemental
1. Survivorship
Model: coxph(Surv(Day.Dead, Dead) ~Fish.Line*Treatment, data=coinfection.ge
n.res.1)
n= 120, number of events= 81
Table 1. Model output for Survivorship.
coef

exp(coef)

se(coef)

z

Pr(>|z|)

Fish.LineARS-Fp-S

0.26125

1.29855

0.32443

0.805

0.4207

TreatmentFP alone

4.20583

0.01491

0.66516

-6.323

2.57e-10 ***

TreatmentIHNV alone

1.97189

0.13919

0.38305

-5.148

2.63e-07 ***

Fish.LineARS-Fp-S:Tr

-0.249

0.779

0.87857

-0.284

0.7763

1.07

2.91

0.48864

2.190

0.0285 *

eatmentFP alone
Fish.LineARS-Fp-S:Tr
eatmentIHNV alone
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
Concordance= 0.884 (se = 0.041 )
Rsquare= 0.682 (max possible= 0.997)
Likelihood ratio test= 137.4 on 5 df, p=0
Wald test

= 91.38 on 5 df, p=0

Score (logrank) test = 143.8 on 5 df, p=0
pairwise_survdiff(Surv(Day.Dead,Censor=="0")~Treatment+Fish.Line, data=coinf
ection.gen.res.2, p.adjust.method = "bonferroni", rho = 0)
Pairwise comparisons using Log-Rank test
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data: coinfection.gen.res.2 and Treatment + Fish.Line
Table 2. Model output for Pairwise comparisons using Bonferroni adjustment

FP TO IHNV
ARS-Fp-S
FP TO Mock
ARS-Fp-R
FP TO Mock
ARS-Fp-S
Mock TO IHNV
ARS-Fp-R
Mock TO IHNV
ARS-Fp-S

FP To IHNV
ARS-Fp-R
1.00000

FP To IHNV
ARS-Fp-S
-

FP To Mock
ARS-Fp-R
-

FP To Mock
ARS-Fp-S
-

Mock To IHNV
ARS-Fp-R
-

1.6e-09

8.7e-10

-

-

-

1.6e-09

8.7e-10

1.00000

-

-

5.5e-08

6.6e-07

9.6e-05

0.00013

-

1.00000

0.40340

3.0e-08

3.0e-08

0.00102

P value adjustment method: bonferroni
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2. Number of fish shedding each pathogen
2.1 Viral Shedding
Virus Model: glmer(cbind(New.Number.for.Positive.Count,Number.for.neg.count)
~ Fish.Line+Treatment+Day+ Fish.Line*Treatment+ (Day|Tank.Number) , family=
binomial, data=prop.suc.fail.df3.ihnv)
Generalized linear mixed model fit by maximum likelihood (Laplace Approximatio
n) ['glmerMod']
AIC
530.9

BIC logLik deviance df.resid
567.5 -257.4

514.9

716

Table 3.Model output for number of fish shedding virus over time.
Estimate Std. Error

z value

Pr(>|z|)

(Intercept)

3.8628

0.4826

8.003 1.21e-15 ***

Fish.LineARS-Fp-S

0.6328

0.4352

1.454

0.1459

TreatmentIHNV alone

-0.7443

0.4151

-1.793

0.0729 .

Day

-0.3132

0.0453

-6.915 4.69e-12 ***

1.4666

0.6685

Fish.LineARS-Fp-S:Trea
tmentIHNV alone

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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2.194

0.0282 *

Figure 1. Predicted likelihood of shedding virus. The lines represent the trend of
the predicted likelihood of fish shedding IHNV when exposed to each treatment
for the ARS-Fp-R (black) fish line and ARS-Fp-S (gray) fish line. Values are
obtained from statistical models (Supplemental Table 2).

151

2.2 Bacterial Shedding
Model:glmer(cbind(Number.for.Positive.Count,Number.for.neg.count)~ Fish.Line
+Treatment+Day +(Day|Tank.Number), family=binomial, data=prop.suc.fail.df3.fp
)
AIC
747.6

BIC logLik deviance df.resid
779.7 -366.8

733.6

712

Table 4.Model output for number of fish shedding bacteria over time.
Estimate

Std. Error

z value

Pr(>|z|)

2.68509

0.24995

10.742

<2e-16 ***

Fish.LineARS-Fp-S

-0.09029

0.19534

-0.462

0.644

TreatmentFP alone

-1.91053

0.21495

-8.888

<2e-16 ***

Day

-0.21128

0.02118

-9.974

<2e-16 ***

(Intercept)

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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3. Mean intensity of pathogen shed
3.1 Viral Shedding
Model: lme(New.Log.Quantity~Day+Treatment+Fish.Line+Treatment:Fish.Line, r
andom=~Day|Tank.Number, data=quant.data.ihnv,+ method="ML", na.action="n
a.omit", weights=varExp(), correlation=corAR1())
Random effects:
Formula: ~Day | Tank.Number
Structure: General positive-definite, Log-Cholesky parametrization
StdDev

Corr

(Intercept) 5.360969e-05 (Intr)
Day
Residual

4.366963e-06 0
7.928213e-01

Table 5.Model output for mean intensity of viral shedding over time.
Value

Std.Error

DF

t-value

p-value

4.608680

0.105667

491

43.61507

0.0000

Day

-0.074890

0.010884

491

-6.88019

0.0000

TreatmentIHNV alone

-0.425468

0.132742

76

-3.20522

0.0020

Fish.LineARS-Fp-S

0.235062

0.126960

76

1.85145

0.0680

TreatmentIHNV alone:

0.458571

0.181619

76

2.52490

0.0137

(Intercept)

Fish.LineARS-Fp-S
Number of Observations: 572
Number of Groups: 80
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3.2 Bacterial Shedding
Model: lme(Log.Quantity~Day+Treatment+Fish.Line, random=~1|Tank.Number,
data=quant.data.fp, + method="ML", na.action="na.omit", weights=varExp(), corr
elation=corAR1())
Random effects:
Formula: ~1 | Tank.Number
(Intercept)

Residual

StdDev: 0.1441848 0.002894812
Table 6.Model output for mean intensity of bacterial shedding over time.
Value

Std.Error

DF

t-value

p-value

4.495232

0.06035889

262

74.47506

0.0000

Day

-0.004657

0.00802392

262

-0.58035

0.5622

TreatmentFP alone

-0.143921

0.06257740

72

-2.29989

0.0244

Fish.LineARS-Fp-S

0.010749

0.05855458

72

0.18357

0.8549

(Intercept)

Number of Observations: 338
Number of Groups: 75
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4. Total amount of pathogen shed
4.1 Viral Shedding
Model: glm.nb(Quantity~Fish.Line+Treatment, data=tot.shed, link=log)
Table 7. Model output for total amount of virus shed.
Estimate

Std. Error

z value

Pr(>|z|)

(Intercept)

1.73465

0.08124

21.353

<2e-16 ***

Fish.LineARS-Fp-S

0.10617

0.09347

1.136

0.256

-0.08536

0.09342

-0.914

0.361

TreatmentIHNV alone

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial (2746610) family taken to be 1)
Null deviance: 4.9500 on 79 degrees of freedom
Residual deviance: 2.8222 on 77 degrees of freedom
AIC: 299.54
Number of Fisher Scoring iterations: 2
Theta: 2746610
Std. Err.: 117686038
2 x log-likelihood: -291.544
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4.2 Bacterial Shedding
Model: glm.nb(Quantity~Fish.Line+Treatment, data=tot.shed, link=log)
Table 8.Model output for total amount of bacteria shed.
Estimate

Std. Error

z value

Pr(>|z|)

(Intercept)

1.67080

0.08575

19.486

< 2e-16 ***

Fish.LineARS-Fp-S

0.02523

0.10280

0.245

0.80614

TreatmentFP alone

-0.27739

0.10378

-2.673

0.00752 **

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial (241800.4) family taken to be 1)
Null deviance: 53.495 on 79 degrees of freedom
Residual deviance: 46.222 on 77 degrees of freedom
AIC: 315.52
Number of Fisher Scoring iterations: 1
Theta: 241800
Std. Err.: 3935406
2 x log-likelihood: -307.518
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ABSTRACT
Economic loss due to morbidity and mortality caused by disease costs United
States aquaculture facilities around six billion dollars a year. Vaccination is used
in many systems to prevent mortality by such diseases. However, there is little
information on how preventative methods, such as vaccines, alter host-pathogen
relationships. Studies are often done to evaluate the efficacy of a vaccine at
reducing disease, but the impact on transmission is rarely studied. Furthermore,
vaccines typically target only one pathogen. Although infection by one pathogen
does occur, it is more common for hosts to be infected by multiple pathogens, i.e.,
they are co-infected. Multiple pathogens can infect the host simultaneously, but it
is more probable that they infect the host sequentially. How vaccination impacts
target and non-target pathogens in simultaneous and sequential co-infections is
largely unknown. These knowledge gaps make it difficult to infer the efficacy of a
vaccine in the field. In an attempt to fill these gaps, we evaluated how vaccination
impacts transmission dynamics during simultaneous and sequential co-infections
of IHNV and F. psychrophilum in rainbow trout (Oncorhynchus mykiss). Our results
indicated that co-infected fish shed more of both pathogens than they do in single
infections and that pathogen order had a relatively small impact on co-infection
dynamics. Vaccine efficacy was also reduced by co-infection. These studies were
aimed at understanding preventative effects on co-infections and how coinfections change vaccine efficacy in the field. Our results inform and improve
disease management in one of the top aquaculture species in the United States.
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1. INTRODUCTION
It is well known that co-infections, or infections with multiple pathogens, are
common in nature (Griffiths et al. 2011, Kotob et al. 2016) and can impact
disease dynamics (Alonso et al. 1999, Byrne et al. 2008, Long et al. 2010,
Lorenzen et al. 2002, Wargo et al. 2010). However, control measures such as
vaccination almost exclusively target and are optimized towards a single
pathogen, when it is infecting the host alone without any co-infecting pathogens
(Hoft et al. 2011). How vaccine efficacy is altered during co-infections is
important for understanding disease dynamics, yet is rarely studied. Even more
importantly, it is difficult to accurately assess true, field-relevant estimates of
vaccine efficacy without considering co-infection.
Although studies are limited, there is evidence that co-infections can hinder
vaccine efficacy (Figueroa et al. 2017) by reducing the immune system’s ability to
fight the vaccine-targeted pathogen, thus resulting in higher target pathogen
loads and increased mortality. In general, a few types of vaccine impacts on coinfection interactions are possible. If there is competitive suppression between
co-infecting pathogens, vaccination may release the non-target pathogen from
competition which could result in more disease than anticipated. If there is
facilitation between pathogens, vaccination may have an added benefit of
suppressing the non-target pathogen because it removes facilitation. If the
interaction is neutral, disease caused by the target pathogen will be removed, but
that caused by non-target pathogens will remain at the same levels (Read and
Taylor 2001).
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In addition to within-host dynamics, the order in which the co-infecting
pathogens infect the host could also alter their interactions and further shape
vaccine efficacy. Improved immune response due to prior infection might lead to
a different interaction than if the two pathogens infect the host at the same time.
For example, it may be more difficult for the second pathogen to get into the host
and establish an infection (antagonistic) or the first pathogen may suppress the
immune system making it easier for the second pathogen to colonize the host
and establish an infection (i.e. synergistic) (Vaumourin et al. 2015). Once in the
host, replication and transmission of both pathogens can be affected by
resource- mediated responses or due to direct pathogen interaction (Ezenwa and
Jolles 2011). Due to these changes in the interactions, the impact on vaccine
efficacy is likely to be altered as well. Ultimately, sequential co-infection is likely
just as common as simultaneous co-infection and the outcomes of vaccine
efficacy in co-infections are virtually impossible to predict without actual data.
In this study, we quantified the impact of simultaneous and sequential coinfection between IHNV and Flavobacterium psychrophilum on vaccine efficacy.
In rainbow trout aquaculture, infectious hematopoietic necrosis virus (IHNV) and
F. psychrophilum are two of the most problematic pathogens that are known to
co-occur and co-infect this host (LaFrentz et al. 2004). IHNV is a single-stranded,
negative-sense RNA virus of the Rhabdoviradae family (Bootland and Leong
1999) that is endemic to salmonid species along the Pacific coast of North
America (Anderson et al. 1996), but has spread worldwide (Rodger 2016).
Flavobacterium psychrophilum is a gram-negative bacterium and the causative
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agent of rainbow trout fry syndrome (RTFS) and bacterial cold-water disease
(BCWD) (Lafrentz and Cain 2004) that can be found globally (Amita et al. 2000;
Bernardet et al. 1988, Rangdale et al. 1997). IHNV and F. pyschrophilum cause
acute disease that results in epidemics in trout farms and hatcheries (Troyer et
al. 2000) with from 90% to 100% (Bootland and Leong 1999). Both pathogens
are mainly transmitted when fish shed the pathogen into the water (Suttle 2007,
Traxler et al. 1993, Nematollahi et al. 2003). The disease caused by each
pathogen is dependent on environmental conditions such as temperature, fish
age, and stress; that is particularly so for F. psychrophilum, which tends to be
opportunistic in nature (Dixon et al. 2016, Nematollahi et al. 2003). Many farms
have F. psychrophilum infections year round, but fish exhibit no signs of disease
(Neiger and Barnes, 2012). Outbreaks of IHNV are also very common at these
farms. Both pathogens are found in the same geographic region, and they are
frequently found in co-infection in the wild (LaPatra 1998), particularly on trout
farms in Idaho (LaFrentz et al. 2004).
Vaccines have been developed against single infections of both IHNV and F.
psychrophilum. Recently a commercial DNA vaccine was approved by the
USDA for use in aquaculture (Salonius et al. 2007), which is highly effective at
reducing disease (Corbeil et al. 1999), but less effective at reducing infection
(Jones et al. submitted, Long et al. 2017). Development of F. psychrophilum
vaccines has been more challenging (Gómez et al. 2014), with many only
showing marginal efficacy in disease prevention. How the efficacy of these
vaccines is impacted by co-infection has not been directly assessed.
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Several studies have examined co-infection between each of these
pathogens and other pathogens, but many focused on the damage caused to the
host or on within-host competition (Alonso et al. 1999, Byrne et al. 2008, Long et
al. 2010, Lorenzen et al. 2002, Wargo et al. 2010). Vendramin et al. (2018) found
an antagonistic effect of piscine orthoreovirus (PRV) on IHNV in co-infection
most likely due to the induction of a protective innate antiviral response. While
Ma et al. (2019) determined that sequential exposure of IHNV then F.
psychrophilum resulted in facilitation. Although these studies provide valuable
insights into the impact of co-infection on damage to the host and pathogen
replication within the host, neither looked at transmission in response to
sequential co-infection or impacts on vaccine efficacy.
We build upon the previous work on IHNV and F. psychrophilum co-infection
by quantifying the impact of vaccination on disease and transmission of IHNV
and Flavobacterium psychrophilum in simultaneous and sequential co-infections,
which informs the effect of co-infection on vaccine efficacy. We were particularly
focused on transmission dynamics because they are critical for pathogen
management and are often overlooked. This is one of the first studies to examine
the effect of co-infection on vaccine efficacy in any system. Results will provide
better estimates of vaccine efficacy in the field. They also provide valuable
insights into disease management in this and other systems.
2. MATERIALS AND METHODS
2.1 Fish line
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Rainbow trout (Oncorhynchus mykiss) were obtained as eggs from Clear
Food Springs, Inc, then reared until 1-3 grams wet weight in specific-pathogenfree water, at 12-15°C, in a recirculating system with 1-3 system wide water
exchanges per day. The fish were from a line (herein labelled IHNV.R) that had
been selected for a variety of aquaculture production enhancing traits such as
growth and resistance to IHNV as well as other diseases (LaPatra and Towner
2006). All fish husbandry and experimental protocols were approved by the
William and Mary IACUC under protocol number IACUC-2014-06-17-9666arwargo.
2.2 Pathogens
Infectious hematopoietic necrosis virus (IHNV, species: Salmonid
novirhabdovirus) genotype C (genbank accession number: AF237984) is part of
the M genogroup and was first isolated in the Idaho trout aquaculture region
(Kurath et al. 2003). For these studies, a new virus stock was propagated by
passing a previous virus stock on Epithelioma Papulosum Cyprini (EPC) cells
(Fijan et al. 1983), and was stored at -80ºC in Eagle’s minimum essential media
(MEM; Gibco) supplemented with 10% fetal bovine serum, as previously
described (Peñaranda et al. 2011). The virus stock was titered by triplicate
plaque assays (Batts and Winton 1989) and found to have a concentration of
7.56 x 108 plaque forming units (PFU)/mL.
F. psychrophilum, strain CSF 117-10, was originally isolated in 2010 from
a clinical outbreak of BCWD. The isolate was cloned, amplified, and frozen by
collaborators at the ARS NCCCWA facility in Kearneysville, WV (Hadidi et al.
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2008). For the challenge, a clonal culture was propagated and enumerated as
described in Jones et al. (unpublished).
To ensure that all fish exposed to both pathogens became infected, high
pathogen dosages were used in both experiments.
2.3 Vaccine
The vaccine used in this study was the DNA vaccine pWg containing the
glycoprotein gene (G) of IHNV genotype WRAC, and propagated using plasmid
Gigaprep kits (Qiagen) from the original transfected bacteria (Corbeil et al. 1999;
Corbeil et al. 2000). This vaccine is heterologous to the virus challenge strain,
IHNV genotype C, used in this study. The vaccine provides highly efficient IHN
disease protection as previously characterized (Corbeil et al. 2000, Garver et al.
2005, LaPatra et al. 2001). Fish from each line were vaccinated with an
intramuscular injection of 0.05 mg of the vaccine in 25 µL of phosphate buffered
saline (PBS) or sham vaccinated with 25 µL PBS. Fish were then placed in 6L
tanks and held at 15ºC for 30 days to allow acquired immunity to develop
(Corbeil et al. 2000). Fish were only vaccinated against IHNV and not F.
psychrophilum.
2.4 Experiment 1 – Simultaneous exposure to pathogens
Thirty days post vaccination, fish were anesthetized in 100 mg/L tricaine
methanesulfonate buffered with 300 mg/L sodium bicarbonate. Once
anesthetized, fish were challenged with an intraperitoneal (i.p.) inoculum using a
27G ½” needle and syringe with 50 µL of TYES or F. psychrophilum at 8.5 x 105
CFU/fish. They were then directly placed in a recovery bucket with continuous
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aeration. After the entire group of 20 fish fully recovered, fish were transferred to
new 6 L tanks and were exposed to MEM-10 or IHNV at 1 x 106 PFU/mL through
immersion. In all cases, fish were exposed to IHNV within 5 minutes of being
inoculated with F. psychrophilum. We consider this simultaneous coinfection due
to the short time between pathogen challenges. After one hour, the fish were
moved to a new 6 L tank where they were washed at a flow rate of 1500-1600
mL/min for one hour to remove excess pathogen inocula. The fish were then
placed individually into randomly assigned 0.8 L tanks in a tower rack system
(Aquatic Ecosystems), with flow-through water and flow rate set to 150 ml/min.
After all fish were distributed (approximately one hour), water flow was turned off,
and a 1ml water sample was taken from each tank (Day 0). The tanks were then
held static for 22 hours, after which time 1ml water was again sampled from each
tank (Day 1). Holding the water static allowed for accumulation of total virus and
bacteria shed over the previous 22-hour period. Water flow was turned on to
150mL/min for a two-hour wash to ensure all pathogens were removed from the
tank (data not shown). This was repeated for Days 0-7. After sampling on Day 7,
tanks were flushed for two hours and then set to 80 mL/min. On Day 9, 24 hours
before sampling, flows were turned to 150mL/min for a two-hour wash to remove
pathogens from the tank. Water was then turned off to all tanks 22 hours before
sampling on Day 10. This process was repeated for Days 15 and 20. Raw, 1 mL
water samples were stored at -80ºC for further processing. The sampling process
allowed us to quantify the amount of virus and bacteria each fish shed per day.
Water temperature was maintained at 15ºC ± 1°C throughout the experiment.
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Fish were taken off feed 24 hours prior to the experiment and then fed on
Monday, Wednesday, and Friday from Day 1 forward. Over the 30-day course of
the experiment, 63 fish died; however, those fish were kept in their tanks and the
water sampled as described above. At the end of the experiment, all of the
remaining fish were euthanized with an overdose of 0.27 mg/ml tricaine
methanesulfonate buffered with 0.09 mg/ml sodium.
2.5 Experiment 2 – Effects of sequential infection on fish
Experiment 2 contained 9 different treatments to control for timing
differences in pathogen exposure (Table 1). In general, a similar protocol was
used as described for experiment 1, but with the addition of sequential pathogen
exposure group (and appropriate controls), which had a 12 hour delay between
exposure to the two pathogens (IHNV and F. psychrophilum). A 12 hour delay
was chosen because fish are shedding by 24 hours post-exposure which may
have resulted in secondary infections when the fish were held as a group
overnight and 12 hours was a manageable time for experiment set-up. Briefly, 30
days post-vaccination, fish were exposed to one of five treatments: (1) injection
with 50ul TYES (Mock Fp), (2) injection with 2.4 x 106 CFU F. psychrophilum in
50 ul TYES, (3) 1 hour immersion in 995 mL water with 5ml MEM-10 (Mock
IHNV), (4) 1 hour immersion in 995 mL water with 1 x 106 PFU/mL IHNV in 5ml
MEM-10, (5) unhandled. After exposure, all groups of 18 fish were transferred to
clean 6 L tanks and were washed for one hour in flowing water at 1500-1600
mL/min. Flow was then turned down to 100 mL/min and fish held for 12 hours.
Fish were exposed to one of the five treatments above as outlined, with the

166

exception of the unhandled control which was exposed to IHNV and F.
psychrophilum simultaneously. Fish underwent a different treatment in the
second than the first exposure in a fully factorial design (Table 1). After the
second exposure, fish were transferred to clean 6L tanks and were washed for
one hour to remove any residual pathogens. Fish were then placed individually
into randomly assigned 0.8 L tanks in a tower rack system (Aquatic Ecosystems).
The sampling procedure was the same as for experiment 1. Over the 30 day
course of the experiment, 191 fish died; however those fish were kept in their
tanks and continued to be sampled as described above.
2.6 Sample Processing
DNA and RNA was extracted from 210 µL of the water samples using the
cador Pathogen 96 Qiacube HT Kit (Qiagen) with a Tecan Freedom Evo 100
liquid handling robot, as per manufacturer guidelines with modifications from
Jones et. al. (unpublished). Bacterial DNA was quantified by qPCR at the
NCCCWA (Kearneysville, VA), while viral RNA was quantified by qPCR at VIMS
(Gloucester Point, VA) using protocols previously described in Jones et al. (in
prep.).
2.7 Statistics
Statistical analyses were carried out in R, version 3.2.2 (R Core Team
2015) and RStudio (RStudio Team 2015). For all analyses, assumptions of
homogeneity of variance and normality were tested with residual plots, Levene’s
tests, and Shapiro-Wilk tests. Minimal models were chosen using AIC values,
with differences greater than 2 considered significant. Under the assumption of
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parsimony, the simplest model that converged, with equal or lower AIC was
chosen. The best fit minimal models are provided in the supplement, with
statistical inferences presented in the results. The bacteria and virus data were
analyzed separately, because the goal was to determine how the performance of
a pathogen was impacted by vaccination, in the presence and absence of coinfection. Furthermore, comparisons were only made between treatments where
exposure to a given pathogen occurred at the same time. For experiment 2, this
resulted in two separate analyses for each pathogen (IHNV or F. psychrophilum)
containing the following treatments (with and without vaccination): (1) Pathogen 1
alone to pathogen 2 mock (single infection), pathogen 1 to pathogen 2
(sequential infection); (2) pathogen 2 mock to pathogen 1 mock, pathogen 2 to
pathogen 1, pathogen 1 and 2 simultaneous. For experiment 1, there was only
one analysis per pathogen, which included the treatments pathogen alone and in
competition (with and without IHNV vaccination), because all exposure of a given
pathogen occurred at the same time. For survivorship analysis all treatments
were analyzed together, even those with different pathogens. Of the 1600 viral
samples that were processed, 3 samples tested positive out of the 800 negative
controls (fish not exposed to virus), which indicates a false positive rate of
0.375%. Of the 1600 bacteria samples that were processed, 18 samples tested
positive out of the 800 negative controls (fish not exposed to bacteria), which
indicates a false positive rate of 2.25%. After this correction, all mock control
groups were dropped from the figures and analyses.
2.7.1 Survivorship
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Survival was visualized using Kaplan Meier Analysis with the survfit function in
the Survival package in R. Analyses were done using Cox proportional hazard
models in R with the coxph functions in the Survival package (Therneau 2015)
and the pairwise_survdiff function from the Survminer package (Kassambarra et
al 2017). Explanatory fixed factors in each of the models were vaccine (sham
vaccination, IHNV vaccination) and pathogen treatment (IHNV alone, FP alone,
simultaneous co-infection, and sequential co-infection). Their interactions were
also included. Pairwise comparisons using a Long-Rank test with a Bonferroni
correction were used to reveal statistical differences between treatment levels.
2.7.2 Number of fish shedding each pathogen
Number of fish shedding was analyzed with a logistic regression. The response
variable in the model was the proportion of a fish shedding per day (cbind
(number positive, number negative)) as indicated by a positive water sample.
Day 0 and the negative control were not included in the model because our goal
was to determine if shedding differed between treatments from the point
shedding began, forward. Explanatory fixed factors in each of the models were
vaccine, treatment (as described in section 2.7), and day. Their interactions were
also included. A unique identifier for each fish (fish ID) nested in day was
included in the model as a random factor, because the same fish were sampled
at multiple time points (repeated measures). Data was analyzed using the glmer
function in lme4 package (Bates et al. 2015) in R, with a binomial data structure.
2.7.3 Mean intensity of each pathogen shed by positive fish only

169

The intensity of pathogen shedding through time was compared among
treatments during the peak shedding period. To do so, daily quantity of pathogen
shed was analyzed with mixed effects models in R with the lme function in the
nlme packages (Pinheiro et al. 2015). The response variable in the model was
log10 +1 transformed RNA copies of IHNV or DNA copies F. psychrophilum per
mL. Explanatory fixed factors were vaccine, treatment (as described in section
2.7), and day. Fish ID nested in day was included in the model as a random
factor, because each fish was sampled at multiple time points (repeated
measures). Maximum likelihood estimation of parameters was used due to its
ability to handle samples size of less than 30 per treatment. Water samples from
Day 0, the negative control, and with no detectable pathogen were dropped from
the analysis because our goal was to determine if the amount of shedding
differed between treatments for fish that were actively shedding a pathogen, from
the point shedding began, forward.
2.7.4 Total amount of pathogen shed
Total amount of each pathogen shed in each treatment was analyzed using a
negative binomial regression with the glm.nb() function in the MASS package in
R (Venabeles & Ripley 2002). The response variable was the amount of
pathogen shed by each individual fish per day totaled over the experiment and
then log10 transformed +1. Explanatory fixed factors were vaccine and treatment
(as described in section 2.7). Their interaction was also included. The negative
control treatment was dropped from the analysis, because we were interested in
comparing fish line and treatment impacts on shedding between fish exposed to
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a pathogen. However, fish exposed to pathogen that did not shed, were included,
and set to zero.
3. RESULTS
3.1 Survivorship
In experiment 1 mortality began around Day 4 and continued until Day 27
(figure 1a), with the peak window being from Day 5-15. Mortality occurred in all
groups except for the vaccinated fish exposed to IHNV alone and the negative
control group. In all cases, co-infection exacerbated mortality when compared to
single infections of each pathogen (Supplemental table 2, p-values<0.01). This
effect was stronger for IHNV compared to FP (figure 1a), likely because IHNV
alone caused significantly less mortality overall than FP alone (Supplemental
table 2, p-value<0.001). Vaccination also significantly reduced mortality
(Supplemental table 1, p-value<0.001) such that unvaccinated fish had a 78%
higher chance of dying, overall. The vaccine diminished mortality levels in coinfection, but did not reduced levels to that of single infections. Despite potential
trends, the model did not reveal statistical differences in vaccine efficacy
between infection treatments. The model showed differences in interaction
between vaccine and treatment had a delta AIC of 2 higher and was not chosen
due to rules of parsimony.
The kinetics of mortality in experiment 2 were similar to the experiment 1,
with the majority of fish dying between Days 3 and 12 (figure 1b). Again, the
vaccine reduced mortality, here by 60% overall, despite positive trends that the
vaccine effect was stronger for some treatments than others (Supplemental table
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3, p-value<0.05). The effect of co-infection depended on the pathogen. For
IHNV, there was a significant increase in mortality due to co-infection, regardless
of which pathogen infected the host first (Supplemental table 4, p-value <0.01).
For F. psychrophilum, neither simultaneous nor sequential co-infection increased
mortality compared to single infections. The different effect of competition on the
two pathogens could be because mortality was substantially lower for IHNV
compared to FP alone (Table 4, P<0.001). Furthermore, there was no statistical
evidence that the order or timing of pathogen exposure affected survival in coinfections, despite negative trends that initial exposure to FP might enhance
mortality.
3.2 Number of fish shedding each pathogen
For the virus, the number of fish shedding peaked at Day 2 and decreased
over time (figure 2) in both experiments. The analyses for both experiments
revealed that, in most cases, unvaccinated fish had a higher probability of
shedding virus compared to vaccinated fish, in both single and co-infections
(Supplemental figures 1, 2, and 3, Supplemental tables 5,6 and 7, pvalues<0.001). Overall, there was a general decrease in the probability of
shedding through time, but the rate of decrease depended on infection and
vaccine treatment. In experiment 1, the probability of fish shedding pathogens
decreased at a much slower rate in co-infected fish compared to those exposed
to IHNV alone (Supplemental figure 4, p-value<0.001). A similar effect was
observed in experiment 2, but was most pronounced when IHNV came second,
in vaccinated fish (Supplemental figure 2). This was because the vaccinated fish
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exposed to IHNV alone cleared the virus more quickly than in other treatments.
When IHNV came first, vaccination cleared the virus faster regardless of infection
type (Supplemental figure 1), and co-infection increased the overall probability of
shedding, but only in the absence of vaccination (Supplemental figure 3). In
general, there was no significant effect of pathogen order or timing, for coinfections (Figure 2 and Supplemental figure 4).
Bacterial shedding in experiment 1 peaked between Days 1 and 5 and
only decreased slightly before remaining high for the remainder of the experiment
(figure 3a). Shedding was slightly different in the experiment 2 in that most fish
continued to shed pathogens until Day 10, after which the number decreased
sharply (figure 3b). The probability of shedding decreased through time in both
experiments (Supplemental tables 8, 9 and 10, p-values<0.05). This was slightly
faster for vaccinated groups in experiment 2 but was only significant when FP
came first (Supplemental figure 5 and 6). There was also an indication of initially
higher probability of shedding F. psychrophilum in the vaccine treatment, but
again, this was only significant when F. psychrophilum came first (p-value<0.05).
Finally, there was little indication of a competition effect, except for when F.
psychrophilum came second which revealed a significant competition effect when
in sequential co-infection compared to simultaneous co-infection. However, this
was apparently minimal and only occurred in one co-infection group
(Supplemental tables 9 and 10, p-value<0.05).
3.3 Mean shedding intensity
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In general, viral shedding intensity peaked between Days 2 and 4, and
then began to decrease, most particularly in the vaccinated, single infection
treatments (figure 4). In an effort to compare viral shedding intensity, the daily
amount of virus shed was analyzed for only those fish shedding detectable virus
(see Methods). Vaccination, in general, had no effect on the intensity of viral
shedding (Supplemental tables 11, 12, and 13, p-values>0.05). The one
exception was in experiment 2, when IHNV came first, where IHNV alone
actually shed more in vaccination. Co-infection diminished this vaccine effect by
increasing shedding intensity in unvaccinated fish and decreasing it in vaccinated
fish, such that the intensity of shedding was the same between vaccine and
sham treatments in co-infection (Supplemental figure 7). In general, the initial
shedding intensity was higher and the rate of decrease in shedding intensity
through time was slower for co-infection compared to single infection
(Supplemental figure 8 and 9). The exception to this was in experiment 2, when
IHNV came second, where the rate of decrease in intensity was faster for coinfection (Supplemental figure 10). However, there were no clear differences
between sequential and simultaneous co-infection.
Unlike viral shedding, bacterial shedding intensity was fairly consistent
between treatments over time (figure 5). Analyses from experiment 1 suggested
that co-infection exacerbated shedding intensity compared to single infections
(Supplemental table 14, p-value=0.03). In experiment 2, simultaneous coinfection had greater shedding intensity compared to the FP than IHNV treatment
(Supplemental tables 15 and 16, p-value<0.05), but not compared to single
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infection (p-value>0.05). In all cases, shedding intensity decreased significantly
over time (p-value<0.05). The vaccine had no impact on intensity of bacterial
shedding (p-values>0.05).
3.4 Total amount of pathogen shed
In an effort to compare absolute pathogen fitness between treatments
(figures 6 and 7), the total amount of each pathogen shed by each fish was
analyzed. Analyses of both experiments for IHNV and F. psychrophilum revealed
that there was no difference in the total amount of pathogen shed between
vaccine or pathogen treatments within an experiment (Supplemental tables 1722, p-value>0.05). For the virus, there was a trend that vaccinated fish shed less
across all pathogen treatments (single and co-infection), but this was not
significant. Thus, vaccination was ineffective at controlling the total amount of
pathogen shed, for either the virus or bacteria.
4. DISCUSSION
This is one of the first studies to investigate vaccine effects on mortality
and transmission of two different pathogens in simultaneous and sequential coinfections. This study provides an estimate of vaccine efficacy under naturally
variable field conditions. Results suggest facilitation between infectious
hematopoietic necrosis virus (IHNV) and F. psychrophilum, where-in co-infection
exacerbated mortality and number of fish shedding for both pathogens. These
findings confirm previous studies (Jones et al. unpublished, Ma et al. 2019) and
field data (LaFrentz et al. 2004). Vaccination also played a role in reducing
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effects of co-infection in certain treatments; however, both pathogens were still
shed in large quantities, and vaccine efficacy was diminished by co-infection.
In general, the increase in mortality and shedding due to co-infection was
most pronounced for IHNV compared to F. psychrophilum. Furthermore,
mortality overall was much lower for single infections of IHNV (mortality=10%)
compared to F. psychrophilum (mortality=40%). This is consistent with the
historical background of selective breeding for resistance against IHNV in this
fish line (LaPatra and Towner 2006). Certainly, other factors such as pathogen
strain, dose, and delivery method are likely to influence which pathogen is more
pathogenic (Dixon et al. 2016, Nematollahi et al. 2003). However, if this effect
was driven by genetic resistance, our results indicate that this resistance is easily
overwhelmed by co-infection. In fact, these two pathogens appear to act in a
synergistic manner, where the level of disease is greater than simply an addition
of levels observed by each pathogen alone. As such, selective breeding
strategies that target a single pathogen may not be effective in situations where
co-infections are common, which is particularly important in this system.
Similar to the potential impacts on resistance, co-infection was also found
to significantly reduce vaccine efficacy. Again, this was most pronounced for the
virus, which is not surprising given that the vaccine targeted IHNV rather than
FP. In many cases, disease and shedding levels in co-infection were reduced to
that of FP alone, after vaccination, which is what would have been expected if
the vaccine completely reduced all disease effects due to IHNV, as is commonly
observed for this vaccine (Corbeil et al. 1999, Corbeil et al. 2000). The effect was
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also more pronounced for pathogen shedding rather than disease, in that total
mortality was reduced by vaccination in co-infection, yet total shedding was not.
Vaccination did result in more rapid viral clearance of infections in some cases,
but again, this effect was often diminished by co-infection, which often drastically
slowed viral clearance. If vaccine efficacy had been as high in co-infection as
single infections, it would have reduced the level of disease and shedding in coinfection to the levels of single infections, which was generally not the case.
Collectively, these results shed light on the potential immune mechanisms
behind competitive facilitation and vaccine efficacy. The effect seems to be
stronger for the virus, suggesting that the bacteria was more immune stimulatory.
This could be because fish elicit a type II immune response to fight F.
psychrophilum (Henriksen et al. 2015), which suppresses the type I immune
response used to defend against IHNV (Purcell et al. 2004). This was supported
by the increase in viral shedding and disease in co-infection. Additionally,
simultaneous co-infection exacerbated disease slightly more than sequential coinfection. However, this was only seen for the bacteria. Simultaneous co-infection
may overwhelm the host leading to increased shedding intensity and fish
infection. Whereas in sequential co-infection, if the bacteria initiate a type II
response quickly, the host may be able to control bacterial replication,
decreasing the intensity of bacteria shed and the number of fish infected.
In a sequential infection study by Ma et al. (2019), fish with IHNV in coinfection with F. psychrophilum had higher mortality than those with F.
psychrophilum in co-infection with IHNV. However, we found no difference in fish
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mortality in sequential co-infections between these pathogens. This could be due
to differences in pathogen strain, delay times, holding conditions, pathogen
exposure dose, or other environmental conditions. This highlights the importance
of considering these conditions when examining co-infection effects, which will
be equally important when evaluating vaccine efficacy.
Surprisingly, there was no difference in either experiment when analyzing
the total amount of pathogen shed over the course of the infection. This could be
because the peak of shedding occurred around Day 2 when all of the fish are
shedding large numbers of pathogens. Similar shedding kinetics were described
by Wargo and Kurath (2012) and Jones et al. (submitted) where the majority of
shedding occurs during this peak period and may overwhelm whatever difference
there would be between treatments at the end of the experiment when fewer fish
are shedding. This is also supported by the finding that the number of fish
shedding virus changed more than the intensity of shedding. So even though the
number of fish shedding virus was dropping rapidly, intensity was not, which
indicates that a few “super-spreaders” were responsible for that majority of the
total virus shed.
This study illustrates the importance of considering not only mortality, but
also pathogen dynamics, co-infection, and transmission when evaluating vaccine
efficacy. There was a facilitation effect of IHNV and Flavobacterium
psychrophilum in co-infection where mortality, number of fish shedding, and to a
small extent mean intensity of IHNV shed increased. Additionally, vaccine
efficacy was reduced by co-infection. As other vaccines are used in the field, it

178

will be interesting to see if different vaccine types have the same reduced
efficacy in co-infection. This would better inform vaccine efficacy in the field as
well as transmission dynamics of both pathogens in co-infection, both of which
can influence disease management. Co-infections are very common in the field,
and their impact on vaccine efficacy in this and other systems warrants further
investigation.
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Figures and Tables

Figure 1. Survivorship of trout exposed to IHNV and Flavobacterium
psychrophilum. Lines represent the Kaplan-Meier survivorship through time, of
unvaccinated (dotted line) or vaccinated fish (solid line), exposed to different
treatments of the pathogens IHNV and F. psychrophilum (denoted by color), in
experiments 1 (a) and 2 (b). Lines that are not visible had zero mortality
(proportional survival =1.0) and overlap.
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Figure 2. Number of fish shedding IHNV per day. Lines represent total number of
fish out of 20 in experiment 1 (panels a) or 9 in experiment 2 (panel b) that had
detectable IHNV shedding by qPCR, through time. Unvaccinated fish are
represented by the dotted line, and vaccinated fish are represented by the solid
line. The color in the legend represents the exposure treatment (see table 1).
Points represent when samples were taken. Lines that are not visible had zero
fish shedding. Some treatments are shown in more than one panel to allow for
comparisons (denoted by same color line). For experiment 2, the analysis of was
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broken into two separate analyses, one containing 1st day exposure data in top
left panel b, and the other containing 2nd day exposure data in remaining 3
panels.
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Figure 3. Number of fish shedding Flavobacterium psychrophilum per day. Lines
represent total number of fish out of 20 (panels a) or 9 (panel b) that had
detectable Flavobacterium psychrophilum shedding by qPCR, through time.
Unvaccinated fish are represented by the dotted line, and vaccinated fish are
represented by the solid line. The color in the legend represents the exposure
treatment. The top panels shows the experiment 1 while the bottom panel shows
sequential co-infection. Points represent when samples were taken. Lines that
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are not visible had zero fish shedding. For experiment 2, the analysis of was
broken into two separate analyses, one containing 1st day exposure data in top
left panel b, and the other containing 2nd day exposure data in remaining 3
panels.
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Figure 4. Virus quantity shed per day. Lines show mean [log10(viral RNA
copies/ml H2O+1)], shed per day of fish exposed to different exposure treatments
(denoted by color), for experiment 1 (a) and 2 (b). Unvaccinated fish are
represented by the dotted line, and vaccinated fish are represented by the solid
line. If no point is shown, all fish were negative. Only fish actively shedding virus
are included in the mean (shedding intensity). Both live and dead fish were
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included. For experiment 2, the analysis of was broken into two separate
analyses, one containing 1st day exposure data in top left panel b, and the other
containing 2nd day exposure data in remaining 3 panels.
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Figure 5. Bacteria quantity shed per day. Lines show mean[log10(bacterial DNA
copies/ml H2O+1)] shed per day from fish exposed to different exposure
treatments (denoted by color). Panel a shows the experiment 1, while panel b
shows the experiment 2. Unvaccinated fish are represented by the dotted line,
and vaccinated fish are represented by the solid line. If no point is shown, all fish
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were negative. Only fish actively shedding bacteria are included in the mean
(shedding intensity). Both live and dead fish were included. For experiment 2,
the analysis of was broken into two separate analyses, one containing 1st day
exposure data in top left panel b, and the other containing 2nd day exposure data
in remaining 3 panels.
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Figure 6. Total amount of IHNV shed over the course of infection. Bars represent
log total quantity of IHNV shed by unvaccinated (gray) and vaccinated (black)
fish when exposed to each pathogen in single and co-infection. Panel a shows
the simultaneous co-infection while panel b shows sequential co-infection. Error
bars represent standard deviation around the mean.
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Figure 7. Total amount of Flavobacterium psychrophilum shed over the course of
the infection. Bars represent log total quantity of Flavobacterium psychrophilum
shed by unvaccinated (gray) and vaccinated (black) fish when exposed to each
pathogen in single and co-infection. Panel a shows the simultaneous co-infection
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while panel b shows sequential co-infection. Error bars represent standard
deviation around the mean.
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TREATMENTS

1ST DAY

2ND DAY

1 MOCK FP THEN

TYES

MEM 10

TYES

IHNV C

3 FP THEN MOCK IHNV

F. psychrophilum

MEM 10

4 FP THEN IHNV

F. psychrophilum

IHNV C

5 MOCK IHNV THEN

MEM 10

TYES

6 MOCK IHNV THEN FP

MEM 10

F. psychrophilum

7 FP THEN MOCK IHNV

IHNV C

TYES

8 IHNV THEN FP

IHNV C

F. psychrophilum

MOCK IHNV
2 MOCK FP THEN
IHNV

MOCK FP

9 (SIMULTANEOUS CO- --------

F. psychrophilum to

INFECTION)

IHNV

Table 1. Treatments for sequential co-infection (experiment 2). Columns provide
pathogen exposure on Day 1 (column 1) and Day 2 (column 2). Treatment 9 is
the simultaneous co-infection group that was exposed to both pathogens at the
same time on the 2nd day, as described for experiment 1.
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Supplemental Tables
1. Survivorship
1.1 Simultaneous exposure experiment
Model: coxph(Surv(time=Day.Dead,event=Censor=="0")~Vaccine+Treatment, da
ta=coinfection.vax.mort.nc)
n= 121, number of events= 63
Table 1. Model output for Simultaneous co-infection survivorship
coef

exp(coef)

se(coef)

z

Pr(>|z|)

1.023

2.7830

0.27237

3.758

0.000171 ***

TreatmentFP alone

-1.217

0.2959

0.28182

-4.320

1.56e-05 ***

TreatmentIHNV alo

-3.641

0.0262

0.61438

-5.927

3.08e-09 ***

VaccineSham

ne
--Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
Concordance= 0.813 (se = 0.039 )
Rsquare= 0.478 (max possible= 0.991 )
Likelihood ratio test= 78.75 on 3 df, p=1.11e-16
Wald test

= 48.81 on 3 df, p=1.428e-10

Score (logrank) test = 73.76 on 3 df, p=6.661e-16
pairwise_survdiff(Surv(Day.Dead,Censor=="0")~Treatment, data=coinfection.vax
.mort.nc, p.adjust.method = "bonferroni", rho = 0)
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Table 2. Model output of pairwise comparison Log-Rank Test with Bonferroni
adjustment
FP TO IHNV

FP alone

0.0014

-

2.6e-12

3.5e-07

FP alone
IHNV alone

P value adjustment method: bonferroni
1.2 Sequential
Model: coxph(Surv(time=Day.Dead,Censor=="0")~Treatment+Vaccine,
data=pe.vax.mort)
n= 324, number of events= 193
Table 3. Model output for Sequential co-infection survivorship

Treatment
VaccineSHAM
---

coef
-0.28346
0.34275

exp(coef)
0.75317
1.40882

se(coef)
0.03346
0.14519

z
-8.472
2.361

Pr(>|z|)
<2e-16 ***
0.0182 *

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
Concordance= 0.683 (se = 0.027 )
Rsquare= 0.223 (max possible= 0.998 )
Likelihood ratio test= 81.63 on 2 df, p=0
Wald test

= 76.05 on 2 df, p=0

Score (logrank) test = 81.63 on 2 df, p=0
pairwise_survdiff(Surv(Day.Dead,Censor=="0")~Treatment, data=pe.vax.mort,
p.adjust.method = "bonferroni", rho = 0)
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Table 4. Model output of pairwise comparison Log-Rank Test with Bonferroni
adjustment
FP to Mock
IHNV to FP
IHNV to mock
Mock to FP
Mock to IHNV
Simultaneous

FP to IHNV

FP to Mock

1.000
1.000
< 2e-16
1.000
<2e-16
1.000

1.000
1.0e-15
1.000
<2e-16
1.000

IHNV to
FP
5.9e-11
1.000
4.7e-13
1.000
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IHNV to
Mock
1.1e-15
1.000
2.5e-10

Mock to
FP
3.2e-16
1.0000

Mock to
IHNV
3.6e-12

2. Number of fish shedding
2.1 IHNV
2.1.1 Experiment 1
Model: glm(cbind(Number.for.positive.count,Number.for.neg.count)~ Vaccine+Tr
eatment+Day+ Treatment*Day , family=binomial, data=prop.suc.fail.df3.ihnv)
Table 5. Model output for Number of fish shedding IHNV

(Intercept)
VaccineSham
TreatmentIHNV alone
Day
TreatmentIHNV alone:Day
---

Estimate Std. Error
0.22122
0.19380
1.26022
0.18408
2.00866
0.39646
-0.10819
0.02298
-0.60007
0.08189

z value
1.141
6.846
5.066
-4.708
-7.327

Pr(>|z|)
0.254
7.59e-12 ***
4.05e-07 ***
2.50e-06 ***
2.35e-13 ***

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for binomial family taken to be 1)
Null deviance: 996.19 on 720 degrees of freedom
Residual deviance: 732.41 on 716 degrees of freedom
AIC: 742.41
Number of Fisher Scoring iterations: 6
2.1.2 Experiment 2
2.1.2.1 IHNV First
Model: glm(cbind(Number.for.positive.count,Number.for.neg.count)~
Vaccine+Treatment+Day+ Vaccine*Treatment+ Vaccine*Day, family=binomial,
data=prop.suc.fail.df3.IHNV.1)
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Table 6. Model output for Number of fish shedding IHNV when exposed to IHNV
first
Estimate Std. Error z value
(Intercept)
4.4053
0.9765
4.511
VaccineSHAM
-1.1802
1.1583 -1.019
TreatmentIHNV alone
0.9977
0.7368
1.354
Day
-1.3727
0.3000 -4.575
VaxSHAM:TrtIHNV alone
-2.5042
0.9321 -2.687
VaccineSHAM:Day
1.0890
0.3057
3.563
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1

Pr(>|z|)
6.44e-06 ***
0.308258
0.175699
4.76e-06 ***
0.007216 **
0.000367 ***

(Dispersion parameter for binomial family taken to be 1)
Null deviance: 298.53 on 215 degrees of freedom
Residual deviance: 143.95 on 210 degrees of freedom
AIC: 155.95
Number of Fisher Scoring iterations: 8
2.1.2.2 IHNV Second
Model: glm(cbind(Number.for.positive.count,Number.for.neg.count)~ Vaccine+Tr
eatment+Day+ Vaccine*Treatment+ Vaccine*Day + Treatment*Day+ Day*Vaccin
e*Treatment , family=binomial, data=prop.suc.fail.df3.IHNV.2)
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Table 7. Model output for Number of fish shedding IHNV when exposed to IHNV
second

(Intercept)
VaccineSHAM
TreatmentIHNV alone
Treatment sim co
Day
VaccineSHAM:TrtIHNV al
one
VaccineSHAM:Trt sim co
VaccineSHAM:Day
TreatmentIHNV alon:Day
Treatment sim co:Day
VaxSHAM:TrtIHNV alone:
Day
VaxSHAM:Trt sim co:Day
---

Estimate
0.15438
1.23293
3.94561
0.78005
-0.08311
-3.53610

Std. Error
0.40470
0.60729
1.35812
0.59125
0.04950
1.52887

z value
0.381
2.030
2.905
1.319
-1.679
-2.313

Pr(>|z|)
0.70286
0.04233 *
0.00367 **
0.18706
0.09317 .
0.02073 *

0.80195
-0.02402
-1.33702
-0.06397
1.16768

1.00986
0.06734
0.46594
0.07481
0.47611

0.794
-0.357
-2.870
-0.855
2.453

0.42713
0.72129
0.00411 **
0.39250
0.01419 *

-0.10141

0.11483

-0.883

0.37715

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for binomial family taken to be 1)
Null deviance: 448.16 on 323 degrees of freedom
Residual deviance: 322.95 on 312 degrees of freedom
AIC: 346.95
Number of Fisher Scoring iterations: 8
2.2 FP
2.2.1 Experiment 1
Model:glmer(cbind(Number.for.positive.count,Number.for.neg.count)~ Vaccine+T
reatment+Day+ Treatment*Day + (Day|Tank.Number), family=binomial, data=pro
p.suc.fail.df3.fp)
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Generalized linear mixed model fit by maximum likelihood (Laplace Approximatio
n) ['glmerMod']
AIC
588.2

BIC logLik deviance df.resid
624.8 -286.1

572.2

712

Random effects:
Groups

Name

Variance Std.Dev. Corr

Tank.Number (Intercept) 0.433558 0.65845
Day

0.009256 0.09621 0.04

Number of obs: 720, groups: Tank.Number, 80
Table 8. Model output for Number of fish shedding FP

(Intercept)
VaccineSham
TreatmentFP alone
Day
TreatmentFP alone:Day
---

Estimate
3.18937
0.45483
-0.66445
-0.19252
0.02100

Std. Error
0.39791
0.32511
0.43122
0.03623
0.04691

z value
8.015
1.399
-1.541
-5.314
0.448

Pr(>|z|)
1.10e-15 ***
0.162
0.123
1.07e-07 ***
0.654

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
2.2.2 Experiment 2
2.2.2.1 FP First
Model: glmer(cbind(Number.for.positive.count,Number.for.neg.count)~ Vaccine+
Treatment+Day+ Vaccine*Day + (1|Tank.Number), family=binomial, data=prop.s
uc.fail.df3.FP.1)
Generalized linear mixed model fit by maximum likelihood (Laplace Approximatio
n) ['glmerMod']
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Random effects:
Groups

Name

Variance Std.Dev.

Tank.Number (Intercept) 1.849

1.36

Number of obs: 216, groups: Tank.Number, 38
Table 9. Model output for Number of fish shedding FP when exposed to FP first
Estimate
9.1632
-4.8489
-0.5988
-0.5874
0.3052

(Intercept)
VaccineSHAM
TrtFP alone
Day
VaccineSHAM:Day
---

Std. Error
2.0640
1.9504
0.7611
0.1297
0.1260

z value
Pr(>|z|)
4.440 9.01e-06 ***
-2.486
0.0129 *
-0.787
0.4315
-4.529 5.94e-06 ***
2.422
0.0154 *

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
2.2.2.2 FP Second
Model: glmer(cbind(Number.for.positive.count,Number.for.neg.count)~
Vaccine+Treatment+Day+ Vaccine*Day + (1|Tank.Number), family=binomial,
data=prop.suc.fail.df3.FP.2)
Generalized linear mixed model fit by maximum likelihood (Laplace Approximatio
n) ['glmerMod']
Random effects:
Groups

Name

Variance Std.Dev.

Tank.Number (Intercept) 3.08

1.755

Number of obs: 324, groups: Tank.Number, 55
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Table 10. Model output for Number of fish shedding FP when exposed to FP sec
ond

(Intercept)
VaccineSHAM
TrtFP alone
Trt sim co
Day
VaccineSHAM:Day
---

Estimate
6.89113
-1.26949
0.95952
2.07719
-0.53370
0.09957

Std. Error
1.95065
1.73007
0.86915
0.93131
0.13059
0.11253

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
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z value
Pr(>|z|)
3.533 0.000411 ***
-0.734
0.463084
1.104
0.269605
2.230
0.025722 *
-4.087 4.37e-05 ***
0.885
0.376281

3. Mean intensity of pathogen shedding
3.1 IHNV
3.1.1 Experiment 1
Model: lme(Log.Quantity~Day+Treatment+Vaccine+Day:Treatment, random=~D
ay|Tank, data=quant.data.ihnv, + method="ML", na.action="na.omit", weights=va
rExp(), correlation=corAR1())
Random effects:
Formula: ~Day | Tank
Structure: General positive-definite, Log-Cholesky parametrization
Table 11. Model output for mean intensity of viral shedding
Value
3.380629
-0.021607
-0.064604
0.139107
-0.102166

(Intercept)
Day
TreatmentIHNV alone
VaccineSham
Day:TreatmentIHNV al
one
Number of Observations: 336

Std.Error
0.120177
0.017028
0.188099
0.099285
0.051855

DF
252
252
252
252
252

t-value
28.13018
-1.26888
-0.34345
1.40108
-1.97020

p-value
0.0000
0.2057
0.7315
0.1624
0.0499

Number of Groups: 80
3.1.2 Experiment 2
3.1.2.1 IHNV First
Model: lme(Log.Quantity~Day+Treatment+Vaccine+Day:Treatment+Day:Vaccine
+Treatment:Vaccine, random=~Day|Tank.Number, data=quant.data.IHNV.1,
+ method="ML", na.action="na.omit", weights=varExp(), correlation=corAR1())
Random effects:
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Formula: ~Day | Tank.Number
Structure: General positive-definite, Log-Cholesky parametrization
StdDev

Corr

(Intercept) 0.204744846 (Intr)
Day
Residual

0.001623481 -0.394
1.323581199

Table 12. Model output for mean intensity of viral shedding when exposed to IHN
V first
Value
4.94133
-0.3786
1.3120

(Intercept)
Day
TreatmentIHNV alon
e
VaccineSHAM
0.66144
Day:Trt IHNV alone
-0.4350
Day:VaccineSHAM
0.0276
TrtIHNV alone:VaxS
-0.67106
HAM
Number of Observations: 115

Std.Error
0.177224
0.072850
0.198484

DF
77
77
31

t-value
27.881791
-5.198246
6.610581

p-value
0.0000
0.0000
0.0000

0.206446
0.074483
0.074885
0.196985

31
77
77
31

3.203930
-5.841178
0.369014
-3.406695

0.0031
0.0000
0.7131
0.0018

Number of Groups: 35
3.1.2.2 IHNV Second
Model: lme(Log.Quantity~Day+Treatment+Vaccine+Day:Treatment, random=~D
ay|Tank.Number, data=quant.data.IHNV.2, + method="ML", na.action="na.omit",
weights=varExp(), correlation=corAR1())
Random effects:
Formula: ~Day | Tank.Number
Structure: General positive-definite, Log-Cholesky parametrization
211

StdDev

Corr

(Intercept) 0.16171257 (Intr)
Day

0.05429427 -1

Residual

0.15452272

Table 13. Model output for mean intensity of viral shedding when exposed to IH
NV second
Value
(Intercept)
4.446244
Day
-0.158344
TrtIHNV alone
-0.416604
Trt sim co
0.04490
VaccineSHAM
0.237974
Day:TrtIHNV alone
0.097742
Day:Trt sim co
-0.03245
Number of Observations: 171

Std.Error
0.17738439
0.02525833
0.23205401
0.22902821
0.12102466
0.05348333
0.03774462

DF
115
115
49
49
49
115
115

t-value
25.06558
-6.26899
-1.79529
0.19607
1.96632
1.82752
-0.85972

p-value
0.0000
0.0000
0.0788
0.8454
0.0549
0.0702
0.3917

Number of Groups: 53
3.2 FP
3.2.1 Experiment 1
Model: lme(Log.Quantity.mL~Day+Treatment+Vaccine, random=~1|Tank.Numbe
r, data=quant.data.fp, + method="ML", na.action="na.omit", weights=varExp(), co
rrelation=corAR1())
Random effects:
Formula: ~1 | Tank.Number
(Intercept) Residual
StdDev: 0.0002517189 6.107239
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Table 14. Model output for mean intensity of bacterial shedding
Value
(Intercept)
4.184207
Day
-0.019814
TreatmentFP alone
-0.183540
VaccineSham
0.142764
Number of Observations: 594

Std.Error
0.08227673
0.00761581
0.08330916
0.08306329

DF
513
513
77
77

t-value
50.85529
-2.60173
-2.20312
1.71874

p-value
0.0000
0.0095
0.0306
0.0897

Number of Groups: 80
3.2.2 Experiment 2
3.2.2.1 FP First
Model: lme(Log.Quantity~Day+Treatment+Vaccine, random=~Day|Tank.Number
, data=quant.data.FP.1, +method="ML", na.action="na.omit", weights=varExp(), c
orrelation=corAR1())
Random effects:
Formula: ~Day | Tank.Number
Structure: General positive-definite, Log-Cholesky parametrization
StdDev

Corr

(Intercept) 1.022194e-05 (Intr)
Day
Residual

1.674508e-15 0
1.217577e+01
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Table 15. Model output for mean intensity of bacterial shedding when exposed to
FP first
Value
(Intercept)
5.402445
Day
-0.052039
TrtFP alone
0.245205
VaccineSHAM
-0.120830
Number of Observations: 173

Std.Error
0.13897550
0.01898908
0.13529364
0.13548450

DF
135
135
34
34

t-value
38.87337
-2.74046
1.81239
-0.89184

p-value
0.0000
0.0070
0.0788
0.3787

Number of Groups: 37
3.2.2.2 FP Second
Model:lme(Log.Quantity~Day+Treatment+Vaccine, random=~Day|Tank.Number,
data=quant.data.FP.2,+method="ML", na.action="na.omit", weights=varExp(), cor
relation=corAR1())
Random effects:
Formula: ~Day | Tank.Number
Structure: General positive-definite, Log-Cholesky parametrization
StdDev

Corr

(Intercept) 2.653780e-05 (Intr)
Day
Residual

3.091772e-06 0
1.144247e+01
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Table 16. Model output for mean intensity of bacterial shedding when exposed to
FP second
Value
(Intercept)
5.321407
Day
-0.057020
TrtFP alone
0.292695
Trt Sim co
0.376371
VaccineSHAM
0.036718
Number of Observations: 266

Std.Error
0.14009519
0.01513808
0.14916769
0.14531074
0.11384730

Number of Groups: 54

215

DF
211
211
50
50
50

t-value
37.98422
-3.76664
1.96219
2.59011
0.32252

p-value
0.0000
0.0002
0.0553
0.0125
0.7484

4. Total amount shed
4.1 IHNV
4.1.1 Experiment 1
Model: glm.nb(Quantity~Vaccine+Treatment, data=tot.shed, link=log)
Deviance Residuals:
Min

1Q

Median

3Q

Max

-0.64439 -0.21403 0.00439 0.15091 0.77458
Table 17. Total amount of virus shed

(Intercept)
VaccineSham
TreatmentIHNV alo
ne
---

Estimate
1.46096
0.07287
-0.09264

Std. Error
0.09346
0.10822
0.10826

z value
15.633
0.673
-0.856

Pr(>|z|)
<2e-16 ***
0.501
0.392

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial(1018875) family taken to be 1)
Null deviance: 7.0291 on 79 degrees of freedom
Residual deviance: 5.8424 on 77 degrees of freedom
AIC: 279.46
Number of Fisher Scoring iterations: 1
Theta: 1018875
Std. Err.: 31463079
Warning while fitting theta: iteration limit reached
2 x log-likelihood: -271.457
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4.1.2 Experiment 2
4.1.2.1 IHNV First
Model: glm.nb(Quantity~Vaccine+Treatment, data=tot.shed, link=log)
Deviance Residuals:
Min

1Q

Median

3Q

Max

-3.00680 -0.06020 0.05809 0.15039 0.39619
Table 18. Total amount of virus shed when exposed to IHNV first

(Intercept)
VaccineSHAM
TrtIHNV alone
---

Estimate
1.5086
0.1323
0.1335

Std. Error
0.1326
0.1467
0.1467

z value
11.374
0.902
0.910

Pr(>|z|)
<2e-16 ***
0.367
0.363

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial(496587.7) family taken to be 1)
Null deviance: 12.271 on 35 degrees of freedom
Residual deviance: 10.626 on 33 degrees of freedom
AIC: 142.48
Number of Fisher Scoring iterations: 1
Theta: 496588
Std. Err.: 15146402
Warning while fitting theta: iteration limit reached
2 x log-likelihood: -134.475
4.1.2.2 IHNV Second
Model: glm.nb(Quantity~Vaccine+Treatment, data=tot.shed.IHNV.2, link=log)
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Deviance Residuals:
Min

1Q

Median

3Q

Max

-2.83435 -0.10695 0.02965 0.16784 0.76411
Table 19. Total amount of virus shed when exposed to IHNV second

(Intercept)
VaccineSHAM
TrtIHNV alone
Trt sim co
---

Estimate
1.39048
0.18384
0.06161
0.08345

Std. Error
0.13174
0.12683
0.15613
0.15531

z value
10.555
1.450
0.395
0.537

Pr(>|z|)
<2e-16 ***
0.147
0.693
0.591

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial(507762.6) family taken to be 1)
Null deviance: 14.339 on 53 degrees of freedom
Residual deviance: 11.920 on 50 degrees of freedom
AIC: 203.05
Number of Fisher Scoring iterations: 1
Theta: 507763
Std. Err.: 13357773
Warning while fitting theta: iteration limit reached
2 x log-likelihood: -193.055
4.2 FP
4.2.1 Experiment 1
Model: glm.nb(Quantity~Vaccine+Treatment, data=tot.shed, link=log)
Deviance Residuals:
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Min

1Q

Median

3Q

Max

-0.58032 -0.13385 -0.00298 0.12681 0.42622
Table 20. Total amount of bacteria shed

(Intercept)
VaccineSham
TreatmentFP alone
---

Estimate
1.66518
0.04051
-0.04912

Std. Error
0.08429
0.09746
0.09747

z value
19.755
0.416
-0.504

Pr(>|z|)
<2e-16 ***
0.678
0.614

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial(2389690) family taken to be 1)
Null deviance: 3.4514 on 79 degrees of freedom
Residual deviance: 3.0245 on 77 degrees of freedom
AIC: 293.18
Number of Fisher Scoring iterations: 1
Theta: 2388999
Std. Err.: 99840257
Warning while fitting theta: alternation limit reached
2 x log-likelihood: -285.184
4.2.2 Experiment 2
4.2.2.1 FP First
Model: glm.nb(Quantity~Vaccine+Treatment, data=tot.shed.FP.1, link=log)
Deviance Residuals:
Min

1Q Median

3Q

Max

-3.4626 -0.0975 0.0579 0.2209 0.4360
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Table 21. Total amount of bacteria shed when exposed to FP first
Estimate
1.86870
-0.05863
-0.01920

(Intercept)
VaccineSHAM
TrtFP alone
---

Std. Error
0.11413
0.13355
0.13350

z value
16.373
-0.439
-0.144

Pr(>|z|)
<2e-16 ***
0.661
0.886

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial(516262.6) family taken to be 1)
Null deviance: 13.874 on 35 degrees of freedom
Residual deviance: 13.661 on 33 degrees of freedom
AIC: 151.85
Number of Fisher Scoring iterations: 1
Theta: 516263
Std. Err.: 15132172
Warning while fitting theta: iteration limit reached
2 x log-likelihood: -143.848
4.2.2.2 FP Second
Model: glm.nb(Quantity~Vaccine+Treatment, data=tot.shed.FP.2, link=log)
Deviance Residuals:
Min

1Q

Median

3Q

Max

-1.09837 -0.09056 0.03394 0.12313 0.34546
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Table 22. Total amount of bacteria shed when exposed to FP second

(Intercept)
VaccineSHAM
TrtFP alone
Trt sim co
---

Estimate
1.804173
0.008729
0.052656
0.112252

Std. Error
0.109544
0.107140
0.133204
0.131314

z value
16.470
0.081
0.395
0.855

Pr(>|z|)
<2e-16 ***
0.935
0.693
0.393

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
(Dispersion parameter for Negative Binomial (2112544) family taken to be 1)
Null deviance: 3.6938 on 53 degrees of freedom
Residual deviance: 2.9533 on 50 degrees of freedom
AIC: 213.98
Number of Fisher Scoring iterations: 1
Theta: 2112544
Std. Err.: 91879539
Warning while fitting theta: iteration limit reached
2 x log-likelihood: -203.984

221

Supplemental Figures

Supplemental Figure 1. Predicted likelihood of shedding through time for fish
exposed to IHNV first. Lines represent best fit linear trend of predicted daily
likelihood of viral shedding, from statistical models (described in methods), for
each vaccine treatment in the experiment 2. The gray shading is the 95%
confidence interval around the model fit line.
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Supplemental figure 2. Predicted likelihood of shedding through time of fish
exposed to IHNV second. Lines represent best fit linear trend of predicted daily
likelihood of viral shedding, from statistical models (described in methods), for
each exposure treatment, represented by colors, for each vaccine type in the
experiment 2.
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Supplemental figure 3. Predicted likelihood of shedding for fish exposed to IHNV
first. Lines represent best fit linear trend of predicted daily likelihood of viral
shedding, from statistical models (described in methods), for each vaccine
treatment, vaccinated (black) and unvaccinated (gray), in experiment 2.
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Supplemental figure 4. Predicted likelihood of shedding IHNV through time.
Lines represent best fit linear trend of predicted daily likelihood of viral shedding,
from statistical models (described in methods), for each exposure treatment in
the experiment 1. The gray shading is the 95% confidence interval around the
model fit line.
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Supplemental figure 5. Predicted likelihood of shedding through time of fish
exposed to FP first. Lines represent best fit linear trend of predicted daily
likelihood of bacterial shedding, from statistical models (described in methods),
for each vaccine treatment in the experiment 2. The gray shading is the 95%
confidence interval around the model fit line.
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Supplemental figure 6. Predicted likelihood of shedding through time for fish
exposed to FP second. Lines represent best fit linear trend of predicted daily
likelihood of bacterial shedding, from statistical models (described in methods),
for each vaccine treatment in the experiment 2. The gray shading is the 95%
confidence interval around the model fit line.
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Supplemental figure 7. Predicted mean virus quantity for each treatment when
exposed to IHNV first. Lines show mean [log10(viral RNA copies/mL H2O)], shed
per fish that were vaccinated (black) or unvaccinated (gray), from statistical
models (described in methods) of experiment 2.

228

Supplemental figure 8. Predicted mean virus quantity over time. Lines show
mean [log10(viral RNA copies/mL H2O)], shed per fish exposed to co-infection
(black) or IHNV alone (gray), from statistical models (described in methods) of
experiment 1. The gray shading is the 95% confidence interval around the model
fit line.
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Supplemental figure 9. Predicted mean virus quantity over time for fish exposed
to IHNV first. Lines show mean [log10(viral RNA copies/mL H2O)], shed per fish
exposed to sequential co-infection (black) or IHNV alone (gray), from statistical
models (described in methods) of experiment 2. The gray shading is the 95%
confidence interval around the model fit line.
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Supplemental figure 10. Predicted mean virus quantity over time for fish exposed
to IHNV second. Lines show mean [log10(viral RNA copies/mL H2O)], shed per
fish exposed to each treatment, represented by colors, from statistical models
(described in methods) of experiment 2. The gray shading is the 95% confidence
interval around the model fit line.
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Summary
This dissertation has demonstrated that many different factors impact
transmission of infectious hematopoietic necrosis virus (IHNV) and
Flavobacterium psychrophilum in single and co-infection. The IHNV DNA vaccine
was very efficient at preventing mortality from IHNV; however, vaccinated fish
were still able to become infected and shed pathogens. Additionally, as dosage
increased, mortality and shedding of both pathogens increased, while vaccine
efficacy decreased slightly. Based on our results, there was little to no impact of
breeding fish for disease resistance on transmission of F. psychrophilum.
Co-infection exacerbated disease, number of fish shedding, duration of
shedding, and mean amount shed, especially during simultaneous co-infection.
This is in-line with observations from the field and previous studies. Preventative
methods, such as vaccination and breeding for disease resistance, were much
less effective during co-infections than in single infections. This may lead to
overestimates of prevention efficacy in the field, given that co-infections are
common, but often not considered. The vaccine was more effective at reducing
disease and shedding of the virus compared to the bacteria, which was expected
given that it was a viral vaccine. Interestingly, we also observed that the effect of
co-infection was stronger for the bacteria in one experiment and the virus in
another, particularly in the context of shedding. However, this depended on fish
line, which highlights the importance of fish genetics.
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Finally, the order in which these two pathogens infect the host seemed to
impact co-infection dynamics. Mortality and number of fish shedding IHNV were
lower when fish were exposed to IHNV first compared to Flavobacterium
psychrophilum first. Similar to simultaneous co-infections, vaccination brought
levels of infection back down to levels of single infection in sequential coinfections.
Results from these studies show that pathogen dosage, co-infections, and
fish genetics need to be considered in disease prevention and management. Our
results indicate that prevention strategies are much less effective than previously
estimated due to natural field variability in these parameters. This work provides
insights into the management of two of the leading pathogens in rainbow trout
aquaculture and can be used to develop a variety of tools such as transmission
models, transmission blocking vaccines and fish lines, and improved vaccine
efficacy inference.
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